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ABSTRACT 
MOLECULAR MODELING STUDIES OF ACETYLCHOLINESTERASE 
by 
Charilaos E. Linaras 
The controversial role of electrostatic interactions in the process of steering of 
acetylcholine into the active site of acetylcholinesterases was investigated in this study. A 
novel methodology was implemented to simulate the process of recognition of 
acetylcholine by Torpedo Californica and both wild type and charge neutralized mutated 
Human AChE. The obtained results suggest the important role of coulombic interactions 
in the steering process. The steering process of selected irreversible AChE inhibitors was 
also simulated supporting the role of electrostatic interactions in the recognition process. 
A novel methodology was also employed to model the covalent adducts of 
Torpedo Californica and Human AChE's with various organophosphate inhibitors and 
the interactions of the organophosphate moieties with the surrounding amino acid 
residues of the active sites of the modeled complexes were analyzed. 
Finally, an automated docking environment and methodology were designed and 
implemented in the prediction of the binding sites in Human AChE of three reversible 
acetyl cholinesterase inhibitors, clinically investigated for the treatment of Alzheimer's 
type senile dementia. The results of the docking analysis reproduce the potency rank of 
the studied inhibitor molecules providing with a wealth of structural information 
consistent with similar studies on Torpedo Californica AChE. The developed tools and 
methodology can be directly applied in database screening for the discovery of new lead 
compounds. 
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CHAPTER 1
INTRODUCTION
Acetylcholinesterase is an enzyme of remarkable physiological significance since it
serves to terminate impulse transmissions at cholinergic synapses by rapidly hydrolyzing
the neurotransmitter acetylcholine. It is an extremely effective catalyst, acting on its
natural substrate acetylcholine at rates usually associated with diffusion-controlled
reactions, in accordance with the enzyme's physiological role, a role whose consequences
are of interest to a wide range of backgrounds, the following list being - by no means
exhaustive. In pharmacotherapy, the treatment of diseases such as Alzheimer's, glaucoma
and myasthenia gravis which have their etiology to malfunctionings in the impulse
termination process, passes through acetylcholinesterase. In the military, the study of
chemical warfare agents is almost exclusively associated with the irreversible reaction of
organophosphate compounds with acetylcholinesterase that causes paralysis and death. in
agriculture, organophosphate insecticides are widely used.
This study is an attempt to shed more light into the functioning of this
biologically important enzyme taking advantage of the enormous advances in the field of
molecular modeling that closely follows those in the computer hardware and software. Of
particular emphasis in this study was the controversial role of the electrostatic interactions
in the process of recognition of cationic ligands by acetylcholinesterases, the irreversible
poisoning of the enzyme by compounds that are used as chemical warfare agents and the
binding of reversible inhibitors/promising drugs in the treatment of Alzheimer's type
senile dementia to Human acetylcholinesterase.
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This thesis is organized into five chapters. In Chapter 2, the focus is on the
controversial role of electrostatic interactions in the process of recognition of the
physiological substrate acetylcholine by the acetylcholinesterases. The history, biological
function and some key structural features of acetylcholinesterases are covered in 2.1. The
literature on the influence of the enzyme's electrostatic field on the rate of diffusional
encounter between the enzyme and the substrate with all the surrounding controversy is
critically reviewed in 2.2. In 2.3, details of the approach used in this part of the study that
involved Torpedo California, Human and charge neutralized mutated Human
acetylcholinesterases are provided and the results with an accompanied discussion follow
in 2.4.
Chapter 3 is devoted to two aspects of the phenomenon of irreversible
organophosphate inhibition of acetylcholinesterases, the simulation of the steering
process of selected irreversible acetylcholinesterase poisons into the enzymes' binding
cavity to evaluate the influence of the enzymes' surrounding electrostatic field and the
modeling of the covalent adducts of the studied organophosphate compounds with
Torpedo and Human acetylcholinesterases to correlate important structural features of the
modeled complexes with the potency of inhibition and the efficiency of the steering
process. An introduction to the military significant phenomenon of irreversible poisoning
of acetylcholinesterases is given in 3.1. The methodology involved in this part of the
study with the obtained results and their discussion are presented in 3.7 and 3.3
respectively.
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The final point of interest of this thesis concerned a systematic docking analysis
of the binding of three reversible acetylcholinesterase inhibitors in Human
acetylcholinesterase and is treated in Chapter 4. The progress in the process of developing
new efficient and selective therapeutic agents in the fight against the Alzheimer's disease
is reviewed in 4.1. The automated docking-based methodology of this part of the study is
given in 4.2 while 4.3 contains the results and their analysis in the identification of the
plausible binding sites and the implications in the area of drug discovery.
Finally.. general conclusions from this work are derived and summarized in
Chapter 5 along with some recommendations for future work.
CHAPTER 2
ELECTROSTATIC INTERACTIONS  IN THE PROCESS OF RECOGNITION
OF ACETYLCHOLINE BY ACETYLCHOLINESTERASES
2.1	 Structure and Function of Acetylcholinesterases
Cholinesterases constitute a family of enzymes which differ in their substrate specificity
and susceptibility to inhibitors among different species. Depending on their substrate
preference, cholinesterases fall broadly into two types although this division is not
absolute and it holds true more in mammalian than in non-mammalian species.
Acetylcholinesterases (AChE) are the enzymes that preferentially hydrolyze acetyl esters
like acetylcholine (ACh) while butyrylcholinesterases (BChE) are non-specific
cholinesterases that prefer other types of esters such as butyrylcholine.
Acetylcholinesterase (AChE, Acetylcholine Hydrolase, E.C. 3.1.1.7) was
discovered in 1938 by David Nachmansohn. It is a 260-kd enzyme located in the synaptic
cleft and can be readily separated from the acetylcholine receptor (Figure 1). Its
physiological role is the termination of impulse transmission at cholinergic synapses by
rapid hydrolysis of the neurotransmitter acetylcholine. A striking feature of this enzyme
is its very high turnover number of 25,000 s which means that is cleaves an
acetylcholine molecule in 40μs (Stryer, 1988).
Neurotransmitters are extracellular signaling molecules released by the
presynaptic neuron at a chemical synapse that relay the signal to the postsynaptic cell. A
neurotransmitter can elicit either an excitatory or inhibitory response with the kind of
response being determined by the receptor activated by the neurotransmitter and not by
the chemical nature of the neurotransmitter.
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Acetylcholine, the physiological substrate of acetyleholinesterase, is a small
positively charged molecule utilized as a neurotransmitter in the process of nerve impulse
transmission. Synapses in which acetylcholine is the neurotransmitter are defined as
cholinergic synapses.
Acetylcholine has short life span. Once it has been exocytosed into the synaptic
cleft and has transferred its chemical signal to its target receptor, the synapse must be
restored to its original resting state through the destruction of the neurotransmitter. In
spite of the fact that most neurotransmitters are taken up by the presynaptic neuron,
acetylcholine is being enzymatically degraded to acetate and choline by
acetylcholinesterase.
AChE's catalytic mechanism resembles that of a diverse group of proteolytic
enzymes known as the serine proteases. Serine proteases, like trypsin and chymotrypsin,
are the most thoroughly understood family of enzymes and they are characterized by the
possession of a peculiarly active serine residue that is essential for their enzymatic
activity.
This serine residue, identified as Ser200 in Torpedo California AChE, is ideally
positioned (proximity and orientation effects) to carry out the nucleophilic attack of the
carbonyl carbon of the physiological substrate ACh to form a tetrahedral intermediate
(Figure 2). In this acetylation step, the imidazole ring of a neighboring histidine residue
(His440 in Torpedo AChE) takes up the liberated proton forming an imidazolium ion
(general base catalysis). This general basis catalysis is aided by a glutamic acid residue
(Glu327 in Torpedo) that is hydrogen bonded to the histidine residue. The tetrahedral
intermediate has a transient existence, decomposing to the acetyl-enzyme intermediate
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under the driving force of proton donation (general acid catalysis) from His440 with the
leaving amine group being replaced by water from the surrounding solvent. Finally, a
reversal of the previous steps, with the water serving as the attacking nucleophile and
Ser200 being the leaving group, known as the deacylation step, leads to the regeneration
of the enzyme.
One of the landmarks in the study of acetylcholinesterases was the elucidation of
the x-ray crystal structure (Figure 3) to 2.8 A of Torpedo Californica acetylcholinesterase
in 1991 by Joel Sussman's group (Sussman et al., 1991).
Acetylcholinesterase molecule is a homodimer, has an ellipsoidal shape with
dimensions —45A by 60 A by 65 A and belongs to the class of a/13 proteins (a 2 (3,
structure) consisting of a 12-stranded central mixed p sheet surrounded by 14 a. helices.
The traditional view of the active site of ACNE consisted of two subsites; a
negatively charged 'anionic' site to which the positively charged quaternary nitrogen
moiety of ACh binds and an esteratic subsite containing the actual catalytic residues. A
second 'anionic' site, the 'peripheral anionic' site, around 14 A from the active site, was
proposed on the basis of the binding of long bisquatemary ligands.
The esteratic site was identified as being consisted of Ser200, His440 and a
glutamate residue, Glu327, instead of the usual aspartate residue in serine proteases.
These three residues form a planar array ,constitute the enzyme's catalytic triad and they
are positioned with respect to the rest of the protein as a mirror image of that seen in the
serine proteases.
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The most remarkable feature of this enzyme though is the existence of a deep and
narrow gorge, the 'active site gorge', —20 A long, that penetrates halfway into the enzyme
and widens out close to its base. The catalytic triad is located towards the bottom of that
gorge. The Opt atom of Ser200, which can be seen from the surface of the enzyme, is
located --4A above the base of the gorge. Fourteen aromatic residues line a substantial
portion of the surface of the gorge. These residues and their flanking sequences are highly
conserved among acetylcholinesterases and they may be important in guiding the
substrate into the active site.
No discernible 'anionic' or 'peripheral anionic' binding sites were identified.
Instead, it is now well established that the quaternary nitrogen of the choline moiety binds
through interactions with the 7 electrons of the aromatic ring of the residue Trp84
(constituting what was believed to be an 'anionic' site) while bisquaternary ammonium
ligands in addition interact with the it electrons of Trp279, the previously called
'peripheral anionic' binding site.
2.2 Literature Review
Electrostatic fields around the surface of proteins are known to play an important role in
molecular recognition and binding due to the long-range nature of the Coulombic
interactions.
The effect of electrostatic steering was shown to enhance catalytic rates of
superoxide dismutase with superoxide ion (Davis et al., 1991) and of triose phosphate
isomerase with glyceraldehyde-3-phosphate (Luty et al., 1993). On the other hand, global
charge-charge interactions do not appear to contribute to the association of dihydrofolate
reductase with folate or NADPH since although the net charge of enzymes from different
sources varies from +3 to -10 they display equivalent catalytic activity (Bajorath et al.,
1991). Therefore the contribution of the electrostatic properties of an enzyme to its
catalytic activity has to be evaluated for each particular enzyme.
Acetylcholinesterase is an extremely efficient enzyme believed to operate at or
near the diffusion control limit (Quinn, 1987). Amino acid sequences of
acetylcholinesterases from different species indicate that these enzymes carry a net
negative charge ranging from -1 le up to -14e (Doctor et al., 1990). Early estimates from
studies of the dependence of the association rates of AChE with various substrates, led to
the conclusion that electrostatic attraction is a driving force for the rapid binding of ACh
to AChE (Quinn, 1987).
The first theoretical study of the role of electrostatic interactions in the process of
recognition of cationic ligands by acetylcholinesterase was in 1993 from .1. McCammon's
group (Tan et al., 1993). In their study, Tan et al. computed the electrostatic field around
the enzyme by solving the Poisson equation
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V Φ = 4π/ε ρ 	 (I)
ε
via a finite difference scheme. The equation relates the electrostatic potential (I) to the
charge density p in the enzyme and the dielectric coefficient c. They modeled the
enzyme-solvent system as a heterogeneous dielectric continuum in which point charges
are embedded. The solvent was modeled as a continuum with a high dielectric coefficient
(c=80) and each atom of AChE as a point charge embedded in a low dielectric (c=2)
sphere. The effect of added salt was not included. The net charge used for the AChE was
-16.
Their results indicated that the electrostatic potential has the general
characteristics of a monopole plus a quadrupole field. Near the enzyme active site the
potential becomes negative while on the side opposite to the active site it becomes
positive. They therefore postulated a mechanism for steering the a positively charged
substrate or inhibitor towards the active site. According to their results, if the substrate is
far from the enzyme, it only sees the net negative charge and is attracted to the enzyme
from all directions. Near the enzyme, the substrate begins to feel the quadrupole field. If
the substrate approaches the active site directly, it is attracted and reacts, if it approaches
the side opposite the active site, it is repelled and then steered toward the active site.
Tan et al. also used Brownian dynamics simulations to calculate the diffusion-
controlled rate constants for the binding of a positively charged ligand to AChE.
Brownian dynamics simulations are used to compute and analyze a large number of
trajectories of one reactant diffusing toward its partner under the influence of any
intermolecular forces. They performed calculations under three different conditions:
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diffusion subject to full electrostatic forces, diffusion subject only to the monopole
moments of the monomers and diffusion without electrostatic forces. For the monopole
calculations a charge of -8 was placed at the center of each monomer. Their results
suggested that electrostatic interactions play a major role in enzyme-substrate encounter.
The diffusion-controlled rate constant increased by an order of magnitude when the
charge on the enzyme was increased by 16 units upon including the monopole
interactions. The rate constant increased by another 65% when the higher moments
(quadrupole) were considered. The rate constant calculated in that study with the full
charge distribution was though 10 times higher than the one calculated by Quinn (Quinn,
1987). The oversimplified model used in that study with the ligand represented by a
sphere and the negligence of orientational criteria were reasoned for the discrepancies.
In 1995, J. McCammon's group, in an attempt to bridge the gap between their
computed rate constants and the experimentally measured ones and improve their
prediction of the dependence of the rate constants on the ionic strength, modified the
model used in the previously performed Brownian dynamics simulations and the criteria
for the encounter of the ligand with the enzyme. The modifications involved improved
representations of the ligands and the electrostatic field of the enzyme. Orientational in
addition to the translational steering effects were considered this time along with
dumbbell-shaped ligand models, consisting of two spheres the diffusion properties and
charge distribution of which approximate those of ACh instead of the bead models they
previously employed. In their published work (Antosiewicz et al., 1995a), they compare
the results on the rate constants calculated for different models of the ligands under the
new electrostatic field model and for different reaction criteria. They concluded that their
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results support the contribution of the electrostatic field to the significant increase of the
encounter rate. It is important to note that the electrostatic field favored one particular
orientation of the dumbbell ligands but it accelerated encounter with the substrate in
either orientation relative to the case of a neutral dumbbell. The steering effect of the
electrostatic field was greater on the dumbbell than on the single-bead ligands. Once
again though the computed rate constants exceeded the experimental values even though
they were lower than the rate constants obtained for the single-bead models. Moreover,
the strong dependence observed experimentally of the encounter rates on the ionic
strength disagrees markedly with the experimental data. Therefore this work didn't
challenge the role of the electrostatic interaction in the recognition process of
acetylcholine by acetylcholinesterase. A combination of Brownian dynamics with
Molecular dynamics simulations was proposed though as a way to overcome the
conformational rigidity imposed on the enzyme.
In 1993, Joel Sussman's group, proposed an 'electrostatic mechanism for
substrate guidance down the aromatic gorge of acetylcholinesterase' (Ripoll et al., 1993).
They evaluated the electrostatic potential and field of ACNE assuming a net charge of -8e
for the x-ray resolved structure of the enzyme. A strong electrostatic dipole was revealed
with a negative potential extending roughly over half of the protein surface and a positive
potential covering the other half The electrostatic dipole was aligned directly along the
axis defining the center of the active site gorge. This indicated that positively charged
molecules, such as the physiological substrate ACh could be drawn toward and clown the
aromatic gorge to the active site. Their results basically supported the results of Tan et. al.
mentioned previously (Tan et al., 1993). The number of charges in the active site gorge is
12
very small, just four acidic residues are present, one of which is a member of the catalytic
triad, but there is a marked preponderance of acidic amino acids in the 'northern'
hemisphere lying above the active site triad and a somewhat smaller preponderance of
basic amino acids in the 'southern' hemisphere.
The contribution of the four acidic residues of the active site gorge to the overall
dipole moment was assessed by neutralizing the charges on their side chains. They
realized then that the dipole is generated by the overall charge distribution throughout the
enzyme and is not merely due to the acidic residues in the active site gorge. Since most of
the acidic residues in the 'northern' hemisphere lie behind the residues that line up the
gorge, they proposed that the electrostatic dipole drives the cationic ACh down the gorge
and the aromatic groups provide a series of low-affinity binding sites for the quaternary
choline group, much like what takes place in an affinity electrophoresis column. The
aromatic groups at the same time play a shielding role since a gorge lined with acidic
residues would bind ACh too avidly to the active site triad.
The up to 1993 undisputed role of the electrostatic interactions in the steering of
charged ligands and inhibitors to the active site of the enzyme was shattered in 1994 by
another milestone publication in the field of cholinesterases of experimental data that
suggested that the surface electrostatic properties of ACNE do not contribute to the
catalytic rate, that this rate is probably not diffusion-controlled and that long-range
electrostatic interactions play no role in stabilization of the transition states of the
catalytic process (Shafferman et al., 1994). The authors claim that the assumption of the
catalytic bimolecular rate being diffusion-limited contradicts the fact that the actually
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measured rate constants for various acetyleholinesterases are about an order of magnitude
lower than the expected rates of diffusion-controlled reactions.
To investigate the contribution of the electrostatic interactions to the catalytic rate
of AChE they generated mutant forms of Human AChE in which up to seven of the
surface negative charges located near the rim of the active-site gorge were neutralized. A
gradual shrinking of the electrostatic potential over the 'northern' hemisphere
corresponding to the progressive reduction of the surface negative charge was observed.
Both single and multiple replacements of acidic residues were studied to ensure no
indirect effects such as conformational changes affecting enzyme stability or allosteric
modulation of the active site could mask the specific contribution of the electrostatic
attraction and complicate the interpretation of the kinetic data. Indeed, none of the single-
site replacements had a major effect on the catalytic properties of the resulting enzymes.
The effect though on the enzyme stability of the enzymic forms carrying multiple amino
acid replacements was not assessed in that study.
The catalytic activity of the single- and multiple-site mutants was examined using
the charged substrate acetylthiocholine (ATC) and its isosteric uncharged analog 3,3-
dimethyl butylacetate (TB) to allow examination of the net effect of charge on the
catalytic properties of the mutated enzymes. These two molecules differ in that the
trimethylammonium moiety is replaced by a t-butyl group and the carbonyl oxygen is
replaced by a sulfur. The kinetics of inhibition of the various mutants were studied also
using edrophonium, a charged, reversible, active-center AChE ligand that is known
(Harel et al., 1993) to interact with regions of the active center similar to those
responsible for the binding of the charged substrate ATC.
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The kinetic constants for reactivity of the mutants towards both the charged and
the uncharged substrates and inhibitor were practically invariant indicating that the
electrostatic attraction doesn't contribute to the reaction rates. Some minor variations in
the values of the Michaelis-Menten constant K,„ were attributed to two specific residues
one of which is known to affect moderately the binding of active-center ligands (Barak et
al., 1994) while the other is located very near the active center.
The conclusion of the work of Shafferman et. al. (Shafferman et al., 1994) that the
rate of the enzyme-substrate reaction is not diffusion-controlled is consistent with the lack
of correlation of the catalytic rate with the charge of the substrate that was previously
reported (Quinn, 1987). They also suggest (Shafferman et al., 1994) that it is possible that
the electrostatic attraction in aqueous solutions is cryptic while in the viscous milieu of
the synaptic cleft it becomes operational. This statement along with the lack of thorough
and careful assessment of the effect of the mutations vicinal to the active-site gorge
studied on the enzymatic stability could be used to challenge the findings reported in this
study.
A yet another Brownian dynamics study inspired by the exciting experimental
findings of the work of Shafferman et. al. (Shafferman et al., 1994) appeared in 1995 by
J. Andrew McCammon and Michael K. Gilson's groups (Antosiewicz et al., 1995b). The
purpose of their work was to investigate whether their previously reported results from
Brownian dynamics simulations, which suggested that the electrostatic steering increases
the hydrolysis rate by increasing the rate of encounter of cationic substrates with the
active site, could be reconciled with the experimental study of Shafferman et al.
(Shafferman et al., 1994) which suggested exactly the opposite. Although their study was
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based on the Torpedo Californica AChE existing crystal structure, the high degree of
sequence homology between Torpedo Californica and Human AChE can provide the
justification for their results. This theoretical study considered the 20 single- and
multiple-site Torpedo Californica AChE homologous mutants of the study of Shafferman
et al. (Shafferman et al., 1994).
They reported that although the induced mutations progressively increase the net
negative charge of the enzyme to zero with a concomitant shrinking of the electrostatic
potential of the enzyme, the magnitude of the dipole moment does not go to zero but falls
off only about 40% while the orientation with the respect to the gorge axis does not
change significantly. They did not, however, observe a clear correlation between the
computed dipole moments of the various mutants and their corresponding measured
apparent bimolecular rate constants. The previous observation of the authors
(Antosiewicz et al., 1995a) that the encounter rate constants for cationic substrates largely
exceed those for neutral ones when the reaction criteria are a short distance inside the
active site gorge suggested that the degree to which the field increases the encounter rate
is likely to correlate best with the fields in the immediate vicinity of the gorge. The
examination of the electrostatic potentials along the gorge axis for both the wild type and
the mutated enzymes showed that the potentials indeed become progressively less
negative as more acidic residues are neutralized but even when all the acidic residues are
neutralized, the potentials along the axis are strongly negative. This fact was reasoned to
explain the agreement of the simulations results with the previous experimental findings
(Shafferman et al., 1994).
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Although the computations in the study of Antosiewicz et al. (Antosiewicz et al.,
199Th) assumed diffusion limitation and predicted electrostatic steering, they reproduced
the experimental results of Shafferman et al. (Shafferman et al., 1994) although the
encounter rate constants for a cationic substrate were found to be significantly larger than
those for a neutral substrate suggesting a significant electrostatic steering effect. The
inherent limitation of this study of course was that the results concerned Torpedo AChE.
Recently, another Brownian dynamics study was published again by J. Andrew
McCammon's group (Antosiewicz et al., 1996) whose objective was to correlate the
calculated rate constants of the charge neutralized mutated Torpedo enzymes considered
in their previous work (Antosiewicz et al., 1995b) with the direction of the dipole
moments of those enzymes.
Their simulations indicated that the modest effects of mutations of surface acidic
residues of Human AChE observed previously experimentally were consistent with the
changes introduced by these mutations in the electrostatic field of the enzyme. The results
obtained revealed that there are no simple correlations between rate constants and such
global quantities as the net charge and the dipole moment. However, for all mutants
characterized by the same direction of dipole moment, the calculated rate constants were
nearly linearly correlated with the number of mutations. Deviations from this correlation
were accompanied by larger changes in the direction of the dipole moment within the
subset of mutants. They claim that their results remain in agreement with the concept of
electrostatic steering by the enzyme. Moreover, they observed that this steering is limited
to relatively short distances from the surface of the protein which could be attributed to
any possible perturbations of the electrostatic field of the enzyme by surrounding (macro)
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molecules. They suggested that the electrostatic steering is accomplished in part by
directing substrate molecules that diffusionally approach the enzyme at the distance of a
few angstroms to the entrance of the gorge and in part by increasing the commitment to
reaction for substrates as they move deeper into the gorge. They warned though that
Human and Torpedo AChE are somewhat different and therefore it couldn't be expected
that mutations of homologous acidic residues have the same effect in both enzymes but
qualitative correspondence might be expected.
This chapter attempts a different approach targeted at the elucidation of the
influence of the electrostatic field surrounding acetylcholinesterases on the process of
steering positively charged substrates or inhibitors into the binding cavity of the enzyme.
Three acetylcholinesterase representatives were studied; Torpedo Californica
acetylcholinesterase, whose x-ray crystal structure has been already elucidated and is
available; Human acetylcholinesterase, whose structure was generated in this study based
on the available structure of the homologous Torpedo Californica AChE; and a charge
neutralized mutated Human acetylcholinesterase, whose structure was also generated
through mutant modeling of the Human AChE. This charge neutralized enzyme which
has seven surface acidic residues mutated has been employed in the experimental study of
Shafferman et al. (Shafferman et al., 1994) which was reviewed above.
The next section describes the methodology used to carry out the investigation of
the role of electrostatic interactions in the substrate steering. This includes the calculation
of the electrostatic potential around acetylcholine, the modeling of Human and mutated
Human AChE and the simulation of the process of steering of acetylcholine into the
active site of the studied enzymes.
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Section 2.4 contains the results obtained from the calculation of the electrostatic
potential of ACh and the simulations of its steering process into the active site gorge
along with the conclusions from this study. A further discussion of the role of
electrostatics in the steering process in view of the results of this investigation.
2.3 Methodology
The x-ray crystallographic coordinates for Torpedo Californica acetylcholinesterase
(Sussman et al., 1991) were obtained from the Brookhaven Protein Databank (PDB Entry
# lace) and the ligand acetylcholine was extracted from the AChE-ACh complex.
The structure of the extracted ligand ACh was minimized to the local minimum
energy state closest to the starting set of atomic coordinates with MAXIMIN2 using
SYBYL 6.2 molecular modeling software (Tripos Inc., 1995) running on a Silicon
Graphics Indigo II workstation. The Powell minimization method of MAXIMIN2 was
utilized which is well suited for a wide variety of problems and is the default
minimization procedure in SYBYL. The Tripos force field (Clark et al., 1989) was used
throughout this study.
The partial charges of the atoms of ACh were calculated using the MNDO
semiempirical molecular orbital method in MOPAC 6.0 (Stewart and Seiler).
Subsequently, the electrostatic potential map around ACh was calculated and displayed
using SYBYL.
The missing atoms from the side chains of 27 amino acid residues (19, 26, 42, 46,
74, 88, 89, 107, 162, 163, 253, 257, 260, 261, 268, 270, 284, 286, 299, 310, 325, 344,
350, 353, 365, 382, 413, 434, 455, 461, 478, 484, 498, 499, 508, 511, 515, 526, 533) in
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the obtained structure of Torpedo Californica AChE were then added with SYBYL.
These are polar surface residues not seen in the electron density map. The orientation of
the added side chains was adjusted to eliminate steric hindrances. The Loop Search
algorithm of SYBYL was then used to construct the missing 486-489 four-amino-acid
segment. The Loop Search facility of SYBYL enables the use of fragments of proteins of
known three-dimensional structure for building of models of unknown protein structures.
The polar hydrogens were added to the structure thus obtained which was then minimized
to achieve good covalent geometry, energetically acceptable hydrogen bonds and total or
near total absence of steric overlaps, until the energy gradient reached a cut-off value of
0.5 kcal mol -
Å-
.
The modeled structure of Torpedo Californica AChE was used as a template to
generate the three dimensional structure for Human AChE through the Homology
Modeling module of LOOK 2.0 (Molecular Applications Group, 1995). The amino acid
sequences of Torpedo Californica and Human AChE's were aligned using the
Needleman-Wunsch algorithm (Needleman and Wunsch, 1970).
This homology modeling methodology of LOOK is based on the work M. Levitt
(Levitt, 1992 and Levitt, 1983). The polar hydrogens were then added to the structure
which was then minimized with MAXIMIN2 of SYBYL 6.2 until again the energy
gradient reached a cut-off value of 0.5 kcal mol -Å.
The three dimensional structure of a charge neutralized mutant Human AChE
enzyme was modeled using again the Homology Modeling module of LOOK. This
enzyme contained mutations of seven acidic surface amino acid residues located in the
rim of the active site gorge as was utilized in the study of Shafferman et al. (Shafferman
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et al., 1994) which was thoroughly discussed previously. The mutations involved were
E84Q, E285A, E292A, D349N, E358Q, E389Q and D390N. This time, the amino acid
sequences of Torpedo Californica AChE and Human AChE bearing these mutations were
aligned and the three dimensional structure of Torpedo Californica was used as a
template again for the modeling of the mutant Human enzyme.
Polar hydrogens were added to the structure of the mutated Human enzyme
obtained through the process described above for the wild type Human AChE and its
geometry was then optimized with MAXIMIN2 of SYBYL 6.2 until the energy gradient
reached a cut-off value of 0.5 kcal mol -
Å-
.
The dipole axes of each one of the three AChE's modeled as previously described
and ACh were aligned with SYBYL 6.2 to create the direction of the most favorable
orientation for the interaction between AChE and ACh.
To study the effect of electrostatic interactions in the steering of ACh towards the
active site of each one of these AChE's a code was developed using the SYBYL
Programming Language to drive ACh from a distance of about 35A towards the Ca of the
serine residue of the enzymes' catalytic triad in the direction of the most favorable
orientation, i.e. the direction of the aligned dipole axes, in  1 Å steps. The code calculated
the total, electrostatic, 1-4 electrostatic and van der Waals energies of the AChE-ACh
complex at each distance while 
Å
Ch was rotated around the common dipole axis. The
energy minimum for the most favorable rotation angle at each distance of the center of
mass of the ligand from the C α  of the serine of the catalytic triad was then recorded and
the structure of the enzyme-ligand complex for the most favorable rotation angle at each
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step was energy minimized with MAXIMIN2 to an energy gradient value of 0.5 kcalmol-1Å
2.4 Results and Discussion
The amino acid sequences of Torpedo Californica AChE (SwissProt Accession ID:
PO4058) and of Human AChE (SwissProt Accession ID: P22303) were aligned using the
Needleman-Wunsch algorithm (Needleman and Wunsch, 1970) as it is implemented in
the Gap function of GCG 8.0(Genetics Computer Group, 1994) and the generated
alignment is shown in Figure 4. The percent similarity calculated is 62.628 while the
percent identity is 54.096.
The root-mean-square deviation of the Ca of the superimposed structures of
Torpedo Californica and Human AChE's is 0.827Å  (Figure 5).
The alignment of the amino acid sequences of Torpedo Californica (SwissProt
Accession ID: PO4058) and the charged neutralized mutant Human AChE's was also
performed with GCG and is shown in Figure 6. Their percent similarity calculated is
62.116 and the percent identity is 53.754.
The root-mean-square deviation of the Ca of the superimposed structures of
Torpedo Californica and charge neutralized mutant Human AChE's is 0.865Å  (Figure 5).
The three dimensional modeled structures of the Human and mutated Human
AChE's were also superimposed (Figure 8). The calculated root-mean-square deviation of
the Cα  is.0.672Å.
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The dipole moments calculated for the wild type Human AChE and the charge
neutralized mutant Human AChE based on the models constructed during the course of
this study were 1018 D and 331 D respectively. This means that the charge neutral
enzyme retains only 32.5% of the dipole moment of the wild type enzyme. In the case of
Torpedo Californica AChE studied by Antosiewicz et al. (Antosiewicz et al., 1995b), the
charge neutralized enzyme that contained mutations of amino acid residues homologous
to the ones of the mutated Human AChE retained 64.5% of the dipole moment of the
corresponding wild type enzyme. Consequently, in the case of the Human enzyme, the
effect of the studied mutations on the dipole moment and therefore on the electrostatic
field surrounding the enzyme is more pronounced than in the case of the Torpedo AChE.
The significant amino acid sequence homology between the Torpedo and Human AChE's
therefore should be used with particular caution in any attempt to explain experimental
results concerning the Human enzyme by performing theoretical calculations on the
Torpedo AChE. This is very significant since, by far, in the absence of a crystal structure
for the Human AChE, the results from theoretical calculations on Torpedo AChE were
extrapolated on the basis of sequence homology.
In the all-trans structure of the extracted ligand ACh, generated as described
above, the calculated MNDO partial charges of its atoms suggest that the +1 total charge
of this molecule is not localized on the quaternary ammonium atom as long regarded;
however, it is the result of the contribution of the partial charges of all the atoms. The
calculated electrostatic potential map around ACh is displayed in Figure 9 with the red
contour representing positive electrostatic potential region.
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The complete three dimensional structure of Torpedo Californica AChE is
displayed in Figure 10. Figure 11 is a depiction of the three dimensional structure of the
charge neutralized mutated Human AChE modeled during the course of this study as
described above. The mutated residues near the rim of the active site gorge of the enzyme
are colored purple.
The values of the total, electrostatic, 1-4 electrostatic and van der Waals energies
of the minimized structures for the most favorable rotation angle at each step of the three
complexes studied, Torpedo Californica AChE-ACh, Human AChE-ACh and mutated
Human AChE-ACh, relative to the corresponding energy values of the global energy
minimum, at various distances of the center of mass of the ligand from the Ca of the
serine residue of the enzymes' catalytic triad (whose Oy is located --4Å above the bottom
of the gorge in Torpedo Californica AChE) are presented in Table 1, Table 2 and Table 3
respectively. A perusal of these tables indicates that the electrostatic energy is the
predominant form of energy. The only exception found were the Human AChE - ACh
and mutated Human AChE - ACh complexes at 7, 9 and 10 
Å
 and at 7, 9 and 11 
respectively. This is due to the existence of significant steric overlaps between atoms of
the substrate and the enzymes, in close proximity to the surface of the enzymes, that give
rise to high van der Waals energy values. The presence of the steric hindrances can be
attributed to the relative enzyme-substrate orientation imposed by the alignment of their
dipole axes. In close proximity of the substrate to the enzyme, there may be a slight
deviation from the direction of the most favorable orientation caused by the particular
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features that characterize the behavior of the electrostatic fields of the enzymes very close
to their surfaces.
The total energy values of the Torpedo Californiea AChE-ACh complex relative
to the global energy minimum at various distances of the center of mass of ACh from the
Ca of the Ser200 residue are presented in Figure 12. No change in the energy of the
complex was observed beyond , 34
Å
 of the center of mass of ACh from the Ca of the
'Ser200 residue of the enzyme's catalytic triad. This indicates that the electrostatic field of
ACNE doesn't affect ACh until they are ≈34Å apart. As the ligand moves closer, the
energy of the complex slightly changes denoting interaction between enzyme and ligand.
A drastic change in energy was observed between ≈20 and4Å, suggesting that the
electrostatic interactions affect the steering of the ligand once it reaches 20-24Å from
the active site, that is only when the ligand is in close proximity to the entrance of the
'active site gorge. Since the energy of the complex doesn't change significantly from
≈34Å to ,≈24Å, the steering of the ligand beyond 24 Å appears to be diffusion-controlled.
Four other steep changes in energy were observed at ≈S5Å, ≈11Å,, ≈13Å and at ≈15Å
preceding the local minimum energy states at ,≈10 , ≈12Å,and4Ånd the global
energy minimum at , 16  respectively. This indicates the presence of at least four
transition states, at ≈5SÅ,113and at5S and the existence of multiple steps in
the catalytic reaction. Only the transition state at ≈-,5Å is associated with the catalytic
reaction since it meets orientation and availability requirements for the nucleophilic
attack to take place.
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Figure 13 presents a plot of the total energy values of the wild type Human
AChE-ACh complex relative again to the global energy minimum at various distances of
the center of mass of the ligand ACh from the Ca of the Ser234 of the catalytic triad of
Human AChE. Similarly to the case of Torpedo Californica AChE discussed above, the
energy of the complex remained invariable beyond ≈35Å while a steep energy change
was again observed between ≈21Å  and ≈24
Å
. These results support again the significance
of the role of the electrostatic interactions in close proximity of the ligand to the active
site gorge of the enzyme.
A number of local energy minima were identified in the case of the Human
enzyme, at ≈6 , ≈8Å,1l15Å,7Å and at20with the global minimum at 17
(16  in Torpedo AChE). Six steep energy changes, suggesting the existence of at least six
transition states, were also located at , ≈12Å, ≈ 16Å and at ≈ 8Å
11Å, ≈13Å and, ≈15Å in Torpedo) preceding the local energy minima at
11Å, and ≈15Å, the global minimum at ≈17Å and the local minimum at ≈20Å,
respectively. The Human enzyme seems therefore to retain three out of the four transition
states identified in Torpedo Californica, at ≈5Å at ≈12Å (≈11Å in Torpedo) and at ≈16Å
(≈15Å in Torpedo). The transition state at ≈5Å is believed to be again associated with the
atalytic reaction, for meeting the proximity and orientation criteria for a neucleophilic
attack.
Finally, the total energy values relative to the global energy minimum for the
barge neutralized mutated Human AChE-ACh complex studied as a function of the
istance of the center of mass of ACh from the Cα  of the active site serine residue is
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plotted in Figure 14. Once more, the energy of the complex remains unchanged beyond
,
36A, while no significant change in the energy is observed between ,,, 20A and , 36A. A
steep energy change takes place at , 19A. This phenomenon is in contrast to the behavior
seen in Torpedo and wild type Human AChE's where the corresponding steep energy
change takes place between 20 and 24A and between ≈21A and ≈24A respectively. This
behavior suggests that the impact of the role of the electrostatic interactions appears when
the ligand is even closer to the active site gorge. This may be attributed to the weakened
electrostatic field as a result of the mutations of the acidic amino acid residues near the
rim of the active site gorge.
The local energy minima identified in the case of the mutant Human AChE were
at	 ≈6Å, ≈8Å, ,≈10Å, ≈12Å and ≈16Å (≈ 	 0Å, ,≈12Å, ,≈14Å and ≈16Å      in Torpedo, ≈6Å ,
≈8
Å
, ≈11Å, ≈15Å, ≈17Å and ≈20Å in wild type Human). The global energy minimum is
located at ≈10  (≈ 16  in Torpedo, ≈17  in wild type Human). Therefore a shift in the
global energy minimum of the complex is observed relative to the consistently located
global energy minimum in Torpedo and wild type Human AChE which could be a
consequence of a 'delayed' role of electrostatic interactions due to the presence of the
mutations and the altered electrostatic field.
A number of transition states were also identified at ≈6Å, ≈7Å9,11and
≈13Å preceding the local energy minima mentioned previously. It is suggested that the
transition state at ≈5  be associated with the catalytic reaction in this case in accordance
with the proximity and orientation requirements for the occurrence of a nucleophilic
attack.
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The results from the simulation of the process of steering of acetylcholine to the
entrance of the active site gorge and into the binding cavity of the three
acetvlcholinesterases studied, indicate the significance of the influence of the charge
interactions on the phenomenon. The consistency that both Torpedo and wild type
Human AChE's have to offer in a number of aspects evaluated, the global minimum
energy location, the location of local minima and transition states and the location of the
diffusion-electrostatics border, the point where electrostatic interactions become
effective, is very significant for a number of reasons.
It first serves the validity of the homology-based model generated in the course of
this study. The modeling of the three dimensional structures of enzymes in the absence of
their x-ray image, using a variety of methods developed for the purpose, is a dream come
true for the field of protein structure prediction, yet undoubtedly a remedy which should
be treated with caution. Second, the observed agreement in the behavior of both the
Torpedo and the wild type Human enzymes is not only important for the phenomenon
studied here, suggesting the similarity in the functioning of the two enzymes, but it also
adds credibility to the geometry of the predicted structure on which the entire study is
based.
The observed consistency also serves to identify the different behavior exhibited
by the mutated Human enzyme as a consequence of the weakened electrostatic field of
the enzyme caused by eliminating the negatively charged amino acid residues near the
rim of the active site gorge.
A summary and a more complete discussion of the influence of the Coulombic
interaction is attempted in 3.3 where the results from the simulation of the steering
process of some irreversible inhibitors become available.
CHAPTER 3
IRREVERSIBLE ORGANOPHOSPHATE INHIBITION OF
ACETYLCHOLINESTERASES: STRUCTURAL AND ELECTROSTATIC
ASPECTS
3.1	 Introduction
Acetylcholinesterases are the main targets of organophosphorous pesticides, insecticides
and cholinergic nerve agents. Inhibition of acetylcholinesterases by organophosphates
occurs through phosphorylation of the active site serine and often leads to paralysis and
death (Aldridge and Reiner, 1972). The acetylcholinesterase-organophosphate conjugates
can then undergo postinhibitory processes, the nature and extent of which depend upon
the structure of the inhibitor and the particular enzyme. Spontaneous reactivation through
displacement of the phosphoryl moiety from the active site is usually very slow (Main,
1976). However, reactivation of phosphorylated cholinesterases is possible using
nucleophilic agents such as atropine and oximes that are used in the therapy of
organophosphate poisoning (Aldridge and Reiner, 1972). However, after phosphorylation
by certain organophosphate compounds, acetylcholinesterases progressively lose their
ability to be reactivated according to first-order kinetics. This process called 'aging' is
due to acetylcholinesterase-mediated dealkylation, through alkyl-oxygen bond scission,
of an alkyl/alkoxy group on the organophosphate moiety, resulting in a formal negative
charge in the acetylcholinesterase-organophosphate conjugate (Berman and Decker,
1986). The phenomenon of aging is particularly pronounced for acetylcholinesterase-
organophosphate conjugates in which the organophosphate moiety contains a secondary
alkyl group such as isopropyl or pinacolyl group (Aldridge and Reiner, 1972).
29
30
The cleavage of the C-O bond may be promoted by the negative charge on the
glutamate adjacent to the phosphorylated serine (Qian and Kovach, 1993) although it
appears that other residues involved in the stabilization of the functional architecture of
the active center play a role in this reaction. A salt bridge formed between the P-0 - of the
dealkylated organophosphoryl moiety and histidine of the catalytic triad could be
responsible for resistance of "aged" acetylcholinesterases to reactivators (Harel et al.,
1991).
Although the aging process is understood on the basis of a carbonium ion
mechanism and depends on the phosphorous stereochemistry in the conjugates, the role
of the enzyme environment in facilitating the process is not well understood.
The objective of this chapter is two-fold; to investigate the role of the electrostatic
interactions in the steering process of selected organophosphate compounds into the
active site gorge of Torpedo Californica and Human Acetylcholinesterases as well as the
interactions of the organophosphate moiety in the acetylcholinesterase-organophosphate
conjugates with the surrounding amino acid residues of the poisoned enzymes. The
results of the structural investigations performed are also correlated with published




The three dimensional structures of the two organophosphate inhibitors under
investigation in the present study, Sarin (isopropyl methylphosphonate) and DFP
(diisopropylphosphorofluoridate) (Figure 15) were built by using the Build module of
Insight (Insight 95.0, Biosym 1995). The phosphorous atom in Sarin constitutes a
stereocenter and the two corresponding enantiomers are designated as Sarin PR and Sarin
PS according to the Cahn-Ingold-Prelog system. The geometries for all these three small
molecules, Sarin PR, Sarin PS and DFP, were then energy minimized to their nearest
local energy minimum states, with MAXIMIN2 using SYBYL 6.2 molecular modeling
software (Tripos Inc., 1995).
To identify low energy conformers for the three molecules under study
overcoming energy barriers, a protocol constituted by molecular dynamics and energy
minimization was devised. In that protocol, the local energy minimum conformations
primarily obtained for the three molecules were subjected to 100 runs of a simulated
annealing schedule implemented through the Dynamics module of SYBYL 6.2. The
schedule involved heating of the molecules to 2000 K for 5000 ps and subsequent
exponential cooling to 300 K for 2000 ps. The results of the simulated annealing
calculations were then analyzed through a SYBYL Programming Language code that
subjected all the generated geometries to energy minimization using MAXIMIN2. The
lowest energy conformation for each molecule was then selected and the MNDO partial
charges of its atoms were subsequently calculated with MOPAC 6.0 (Stewart and Seiler)
implemented through SYBYL. The electrostatic field generated as a result of those
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charges was also calculated and displayed in the form of isopotential contours for each
one of the inhibitors employing SYBYL (Figure 15).
For the elucidation of the role of the electrostatic interactions in the process of
recognition of these three irreversible inhibitors by acetylcholinesterase, the methodology
followed in the study of the steering process of acetylcholine into the active site of
acetylcholinesterase and described in the section 2.3 was undertaken. In the case of the
organophosphate inhibitors only the Torpedo Californica and the wild type Human
enzymes were employed. The low energy conformations obtained as described above
were employed in this part of the study.
To obtain the geometries of the covalent adducts of these irreversible
acetylcholinesterase inhibitors with Torpedo Californica and Human AChE's, 50 runs of
the simulated annealing schedule described above were performed to each one of the
small molecules. A SYBYL Programming Language code was then developed that
generated the covalent adduct of each one of the enzymes with each one of the
conformations generated for each inhibitor by the simulated annealing calculations. The
adduct formation involved simply the creation of a covalent bond between the 0 7 of the
serine residue of the active site and the phosphorous atom of inhibitor with the removal of
the halogen substituent of the organophosphate and of the polar hydrogen of the hydroxyl
of the side chain of the active site serine.
For each adduct, the torsional angle associated with the 0,- P bond was then
varied and the energy of the adduct was recorded for each value of this torsional angle.
The conformation corresponding to the torsional angle of the lowest energy adduct was
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subsequently selected for each enzyme and each inhibitor. Six structures were thus
obtained, Torpedo - Sarin PR, Torpedo - Sarin PS, Torpedo - DFP, Human - Sarin PR,
Human - Sarin PS, Human - DFP which were subjected to energy minimization to a
gradient of 0.05 kcal mol-1 Å-1. This methodology constitutes a very fast, less resource-
demanding yet reliable alternative to the use of molecular dynamics for the generation of
the three dimensional models of the covalent adducts of acetylcholinesterases with
irreversible organophosphate inhibitors. Furthermore, the use of the simulated annealing
calculations and the covalent bond's torsional angle variation conserves the exploration
of space for the covalent modification - modified side chain of the active site serine while
holding the rest of the enzyme rigid.
3.3 Results and Discussion
The structures of the three organophosphate inhibitors considered in the study of the
effect of the electrostatic interactions in the process of irreversible poisoning of
acetylcholinesterase are shown in Figure 15. These are the geometries for Sarin PR, Sarin
PS and DFP, obtained through the combination of the use of simulated annealing and
energy minimization calculations described in the previous section. The calculated
electrostatic maps for these molecules are also depicted in Figure 15. All three inhibitors
are polar molecules and the red and blue contours represent negative and positive
electrostatic potential regions respectively.
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Aeetyleholinesterase-arganophosphate Conjugates
In the modeled three dimensional structure of the Torpedo Californica AChE - Sarin PR
adduct (Figure 16), the phosphonyl oxygen forms a hydrogen bond (1.58 A) with the
amide hydrogen of Gly119 maintaining close contacts to the amide hydrogens of the rest
two members of the enzyme's 'oxyanion hole', Gly118 (2.75 
Å
) and A1a201 (2.97 ).
The Oy of the phosphorylated Ser200 residue also hydrogen-bonds with the amide
hydrogen of Ala201 (1.69 ). G1u199, whose negative charge has been proposed to
stabilize the resulting carbonium ion, is located very distantly from the leaving isopropyl
group and the two oxygens of its sidechain hydrogen-bond with the amide hydrogen of
Gly118 (1.67 and 2.80 ). The methyl and isopropyl substituent groups of the
organophosphate moiety are engaged in hydrophobic interactions with the aromatic
sidechains of Trp84 and Phe331, Phe288, Phe290 and Trp233 respectively. The distance
of the Nε2 atom of the His440 residue of the enzyme's catalytic triad from the alkylated
oxygen is 2.70 .
In the Torpedo Californica AChE-Sarin PS adduct (Figure 17), which is higher
energetically than the Torpedo Californica AChE-Sarin PR conjugate analyzed above,
the phosphonyl oxygen forms again a hydrogen bond (1.61 ) with the amide hydrogen
of G1y119 and is located close to Gly118 (3.53 A from the amide hydrogen) and A1a201
(2.92 A from the amide hydrogen). The Oy of the phosphorylated Ser200 residue forms a
hydrogen bond (1.70 ) with the amide hydrogen of A1a201 and is 3.18 A away from theε
2 atom of His440. Glul 99 is in this adduct closer to leaving isopropyl group while the
NE2 atom of the His440 is 2.93  away from the alkylated oxygen atom of the
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phosphonyl moiety. The methyl and isopropyl groups of the phosphonyl moiety interact
with the aromatic sidechains of Trp233, Phe290, Phe288 and Phe331 and Trp84
respectively.
The phosphonyl oxygen in the Human AChE-Sarin PR conjugate (Figure 18),
forms a hydrogen bond (1.64 
Å
) with the amide hydrogen of Gly153 (homologous to
Gly119 in Torpedo Californica AChE) and interacts with the amide hydrogens of Gly152
(3.08 ) and A1a235 (3.15 ). G1y152 and Ala235 are homologous to the Gly118 and
Ala201 residues of the oxyanion hole of Torpedo Californica AChE. The Oy of the
phosphorylated active site Ser234 forms a hydrogen bond (1.66 ) with the amide
hydrogen of Ala235 and is located 3.35 A away from the Nε2 atom of active site His478.
The distance between the alkylated oxygen and the Nε2 atom of active site His478 is 2.69
A in this adduct. Glu233, which is homologous to Glul99 in Torpedo Californica AChE,
is located distantly to the leaving isopropyl group but it forms a hydrogen bond (l.59 A)
with the amide hydrogen of Gly152. The isopropyl moiety of the organophosphate
engages in hydrophobic interactions with the aromatic sidechains of Trp267, Phe328,
Phe326 and Phe369 (which are homologous to Trp233, Phe290, Phe288 and Phe331
amino acid residues respectively of Torpedo Californica AChE).
The Human AChE-Sarin PS conjugate is characterized by a lower energy than the
corresponding conjugate with Sarin PR (Figure 19). The phosphonyl oxygen forms a
hydrogen bond (1.59 A) with the amide hydrogen of Gly153 interacting with the amide
hydrogens of Glyl52 (3.88 ) and Ala235 (3.13 ). The Oy of the phosphorylated active
site Ser234 forms a hydrogen bond (l.72 A) with the amide hydrogen of A1a235. The
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distance of the alkylated oxygen atom from the Nε2 atom of the active site His478
residue is 3.41  
Å 
while the Glu233 residue is ~ 4  away from the leaving isopropyl
group. The methyl group of the phosphonyl moiety interacts with the aromatic sidechains
of Trp267, Phe328, Phe326, Phe369 and His478.
The phosphonyl oxygen in the Torpedo Californica AChE-DFP adduct (Figure
20), forms a hydrogen bond (1.60 ) with the amide hydrogen of Gly119 19 and is 2.64
and 3.16  away from the amide hydrogens of Gly118 and Ala201 respectively. The Oy
of the phosphorylated active site Ser200 residue forms a hydrogen bond (1.66 ) with the
amide hydrogen of Ala201 and is 3.54  away from the Nε2 atom of His440. The
distances of the Nε2 atom of His440 from the alkylated oxygen atoms are 3.01 and 4.11
A. Glu199 is located close to the isopropyl group (3.53 A) whose corresponding alkylated
oxygen is further away from the Nε2 atom of His440 and it is involved in a hydrogen
bond network with Gly118 (1.64  and 2.71 ) and Gly117 and Tyr130. Only the
isopropyl group whose corresponding alkylated oxygen is closer to the Nε2 atom of
His440 engages in hydrophobic interactions with the aromatic sidechains of Phe288,
Phe331, Trp233, Phe290 and His440.
Finally, in the Human AChE-DFP conjugate (Figure 21), which is energetically
higher than the Torpedo AChE-DFP adduct, the phosphonyl oxygen forms a hydrogen
bond (l.59 A) with the amide hydrogen of Gly153 and is located 3.02 and 3.07  away
from the amide hydrogens of Gly152 and Ala235 respectively. The Oy of the
phosphorylated Ser234 residue of the active site forms a hydrogen bond (1.70 ) with the
amide hydrogen of Ala235 and is 3.28  away from the Nε2 atom of the His478 residue
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of the catalytic- triad. Both alkylated oxygens are located within 2.88 
Å
 away from the
Nε2 of the His478 residue. Glu233 is 3.95  away from the closest isopropyl moiety and
it forms a hydrogen bond with the amide hydrogens of Gly152 (1.59 ) and Gly151 (1.6
). The isopropyl group more distantly located from the Glu233 residue interacts with the
aromatic groups of Phe369, Phe326, Trp267, Phe328 and His478.
The interactions identified above of the various organophosphate moieties studied
with the neighboring amino acid residues of the poisoned enzymes are summarized in
Table 4 and are in excellent agreement with previously published results (Qian et al.,
1993, Ordentlich et al., 1993, Barak et al., 1992).
For the adducts of Sarin PR and Sarin PS with the Human ACNE, the previously
observed (Barak et al., 1992) more unfavourable energy of the Sarin PR adduct is
successfully reproduced. Since the distance of the Nε2 atom of the His amino acid
residue of the catalytic triad from the alkylated oxygen atom of the phosphonyl moiety is
indicative of the facilitation of aging, our results indicate that the proton transfer and
therefore the aging process most readily occur in the Human-Sarin PR adduct than in
Human-Sarin PS. This conflicts with the results of Barak et al. (Barak et al., 1992). The
distance of the Nε2 atom of the active site His from the alkylated oxygen of the
acetylcholinesterase-organophosphate adducts can be used to compare the aging tendency
of the conjugates.
Simulation of the Steering Process
The values of the total, electrostatic, 1-4 electrostatic and van der Waals energies of the
minimized structures for the most favorable rotation angle at each step, obtained with the
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methodology described in detail in Section 2.3, of the six complexes considered, Torpedo
Californica AChE - Sarin PR, Torpedo Californica AChE - Sarin PS, Torpedo
Californica AChE - DFP, Human AChE - Sarin PR, Human AChE - Sarin PS, Human
AChE - DFP, are presented in Tables 5-10. These values, which are relative to the
corresponding energy values of the global energy minimum, are given at various
distances of the center of mass of the inhibitors from the Ca of the serine residue (Ser200
for Torpedo and Ser234 for Human AChE) of the enzymes' catalytic triad.
As mentioned in Section 2.4, in the case of acetylcholine, a positively charged
molecule, the electrostatic energy is the predominant form of energy in the steering
process of acetylcholine into the active site of Torpedo Californica AChE while in the
cases of the wild type and charge neutralized mutant Human AChE's the presence of
significant steric overlaps in close proximity to the surface of the enzyme results in high
van der Waals energy values near the surface of the enzyme and in the predominance of
this form of energy. Although the surface morphology of the enzyme can be the cause of
those steric overlaps, the expected difference in the direction of the aligned dipole
moment axes of the enzyme - ligand system can also function as a major contributor.
A perusal of the Tables 5-10 indicates that the electrostatic energy is by large the
predominant form of energy in all six cases studied. There are three notable though very
isolated exceptions to the above statement, in the Torpedo AChE - Sarin PR, Torpedo
AChE - DFP and the Human AChE - DFP complexes with the steric overlaps appearing
at 16, 15 and 10 A respectively. As mentioned previously, these phenomena are probably
the result of the modified direction of the aligned dipole moment axes of the complexes.
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Also the values reported reflect the energy minimization to which the complexes were
subjected, which leads to the local energy minimum closest to the initial conditions.
These phenomena occur however at distances very close to the active site gorge and
cannot affect any conclusions concerning the behavior at the diffusion-electrostatics
border region.
The total energy values of the Torpedo Californica AChE - Sarin PR complex
relative to the global energy minimum at various distances of the center of mass of Sarin
PR from the Ca of the Ser200 residue are presented in Figure 22. The total energy of this
complex is constant beyond 35 A and as the inhibitor moves closer to the enzyme, the
energy of the complex changes only slightly until enzyme and inhibitor are 24 A apart.
This indicates that the steering of Sarin PR appears to be diffusion - controlled beyond 24
A. This is in agreement with the observed behavior of the Torpedo AChE - ACh complex
reported in Section 2.4. A steep energy change occurs at 24 A suggesting that the
electrostatic interactions affect the steering of the inhibitor when it is in close proximity
to the entrance of the active site gorge of the enzyme. The global energy minimum of the
complex is present at 18 A versus at 16 A in the case of acetylcholine, the natural
substrate of the enzyme. A number of energy minimum states proceeding steep energy
changes is indicative of the existence of multiple transition states and therefore of
multiple steps in the catalytic reaction with Sarin PR preserving the pre-global minimum
point transition state behavior exhibited by acetylcholine. The trend observed for the
electrostatic energy values of the complex resembles that of the total energy values since,
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as aforementioned, the electrostatic energy is the predominant form of energy. The only
difference exists at 16 
Å
 and its etiology was covered also above.
Figure 23 presents the graphical representation of the relative total energy values
of the Torpedo AChE - Sarin PS complex, versus the distance of the center of mass of
Sarin PS from the Ca of the Ser200 residue of Torpedo AChE. The global energy
minimum of the complex is present at 17  (versus at 18  in Sarin PR and at 16  in
acetylcholine). The phenomenon of the multiple transition states - multiple transition
steps in the catalytic reaction is also present here with two out of the three pre-global
minimum transition states of the acetylcholine being conserved. Again in the case of
Sarin PS, the total energy of the complex remains constant beyond 35 A, while it is
effectively invariant between 22  and 35  and the steep change in energy, previously
experienced at 24  now appears at 22 . The significant identity in the trends of the total
and the electrostatic energy values of the complex supports the predominance of the
electrostatic energy in the steering process.
The results from the simulation of the steering process of DFP into the active site
of Torpedo AChE are presented in Figure 24. The first notable difference with the
behavior seen so far for Sarin and ACh is the location of the global minimum at 11  (16
 in acetylcholine, 18  in Sarin PR and 17  in Sarin PS). The energy of the complex is
even in the case of this inhibitor constant beyond 34  and effectively invariant between
23  and 34 . The total and electrostatic energy values exhibit the previously observed
similarity in their trends as a result of the predominant role of the electrostatic energy.
4 1
We start analyzing the steering processes of the three inhibitors into the active site
of the Human AChE considering Sarin PR. The plot of the relative total energy values
with the distance of the center of mass of Sarin PR from the Ca of the Ser234 of the
Human AChE is given in Figure 25. The global energy minimum of the complex is
located in this case at 15 
Å
 (18  in the complex with Torpedo, 17  in the complex
Torpedo AChE - ACh). The relative total energy of the complex is consistently constant
beyond 34  exhibiting only slightly changes between 22  and 34 , behavior which has
been invariantly experienced for all three inhibitors and the natural substrate with both
the Torpedo and the Human AChE. The pattern of the local energy minimum states is
very similar with the one in the Human AChE - ACh case with the trends of the total and
electrostatic energy values being identical in the case of Human AChE - Sarin PR due to
the predominant role of the electrostatic energy in the steering process.
Figure 26 contains the plot of the relative total energy values of the Human
AChE - Sarin PS complex as a function of the distance of the center of mass of Sarin PS
from the Ca atom of the Ser234 residue of the active site of Human AChE. A shift in the
location of the global energy minimum, this time found at 11  is surprising since so far
it consistently resided within 1 - 2  from 16 . No surprises though in the location of the
diffusion - electrostatic energy border region, with constant energy beyond 33  and the
steep energy change happening at 22  signaling the commencement of the electrostatic
energy affecting the energetics of the steering process. The pattern of the locations of the
local energy minimum states is within 1 - 2  preserved when the pattern of the Torpedo
AChE - Sarin PS is considered.
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Finally, the graphical representation of the relative total energy values for the
Human AChE - DFP complex with the distance of the inhibitor from the active site gorge
of the enzyme is given in Figure 27. Two significant deviations from an overall similar
picture in the behavior of the inhibitors and the natural substrate during their steering
process are observed, the location of the global energy minimum of the complex at 5 
Å
and the absence of the steep character in the energy change signaling the "take-over" of
the electrostatic interactions from the diffusion-controlled regime, at 21 . This is also
the only difference in the trends of the total and electrostatic values.
The results of the simulation of the steering process of acetylcholine and the three
irreversible organophosphate acetylcholinesterase inhibitors into the active site gorge of
Torpedo Califórnica and Human acetylcholinesterases have been summarized in Table 11
to further facilitate their proceeding evaluation. The results have been categorized
according to the global energy minimum location, the location of the various transition
states and the diffusion-electrostatics border which signifies the 'take-over' of the
coulombic interactions from the pure diffusional movement of the small molecules.
The location of the diffusion-electrostatics border is consistently present within
1-2  from 23 . The only notable exception existing the charge neutralized mutated
Human AChE and has been attributed (section 2.3) to the weakened electrostatic field of
the enzyme.
The location of the global energy minimum of the complexes follows a more
complicated behavior. The global energy minimum for DPP is consistently present at
very close distances of the inhibitor from the enzyme, closer than in the case of Sarin and
ACh. This could be attributed to the very low affinity of DFP for acetylcholinesterases
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relative to the affinity of Sarin and the natural substrate. The exception in this trend
though is in the case of Sarin PS in the Human ACNE when it is known that
acetylcholinesterases exhibit a stereoselectivity towards the S isomers.
With the exception of the cases just described above, the small molecules
investigated exhibit a similar behavior during the simulation of the steering process. More
significantly, our results support the crucial role of the coulombic interactions in the
recognition process. A further and more critical consideration of the effect of the induced
mutations in the human enzyme on the electrostatic field and the architecture of the active
site of the enzyme is necessary to ensure the preservance of the structural integrity and
the credibility of the published experimental data that deny the influential role of
electrostatic interactions in the steering process. A preliminary investigation in the course
of this study based on the solvation energy calculations of the wild type and the charge
neutralized mutant human enzymes indicates a possible 'refolding' of the mutant enzyme
which could be held responsible for the surprising experimental results of Shafferman et
al. (Shafferman et al., 1994).
CHAPTER 4
AN AUTOMATED DOCKING ANALYSIS OF SELECTED REVERSIBLE
INHIBITORS IN HUMAN ACETYLCHOLINESTERASE
4.1 	 Literature Review
The principal biological role of acetylcholinesterase is to terminate impulse transmission
at cholinergic synapses by rapid hydrolysis of the neurotransmitter acetylcholine. One
strategy to enhance cholinergic neurotransmission is to inhibit acetylcholinesterase.
Anticholinesterase agents are therefore of therapeutic importance and they are currently
under active consideration for managing Alzheimer's disease. Reversible
acetylcholinesterase inhibitors have been tested as alternative drugs for Alzheimer's
disease and produced some mixed results but suggest that these agents may be able to
enhance memory in patients with Alzheimer's type senile dementia.
Different chemical classes of reversible acetylcholinesterase inhibitors have been
synthesized and evaluated as possible therapeutic agents in the treatment of Alzheimer's
type of dementia. Treatment with 1,2,3,4-tetrahydro-9-aminoacridine (THA) has
demonstrated moderate but significant efficacy in Alzheimer's type senile dementia.
THA was recently approved by the FDA becoming the -first available treatment for
Alzheimer's disease in the United States. However the aminoacridines suffer from dose-
limiting hepatotoxic effects which are believed to be structure related. 1-benzyl-4-[(5,6-
dimethoxy-1-indanon-2-yl)methyl]piperidine (E-2020) has attracted much attention as a
possible therapeutic agent in the treatment of mild or moderate forms of Alzheimer's
disease. E-2020 is readily synthesized and has higher potency in inhibiting
acetylcholinesterase, higher selectivity for acetylcholinesterase versus
44
45
butyryicholinesterase and longer duration of action in comparison with tacrine (THA) and
appears also to be devoid of the unfavorable side-effect profile of THA because of its
novel benzylpiperidine structure. E-2020 has successfully completed phase III clinical
studies in the United Stated for treatment of senile dementia disease.
A primary goal behind the synthesis of new series of acetylcholinesterase
inhibitors has been to overcome the serious, potentially lethal side effects of short
duration of action and a narrow therapeutic window of existing anticholinesterase agents
towards the development of more effective and selective compounds. Ligand - receptor
docking analysis along with structure - activity relationship data can aid significantly the
rational drug design process providing further insight into the relationship between the
biological activity and the structure of various anticholinesterase agents through an
understanding of the key modes of interactions of the ligand with the receptor.
The availability of the crystal structure of the receptor Torpedo Californica
acetylcholinesterase (Sussman et al., 1991) provided a wealth of information regarding
the existence of multiple ligand binding sites and the functionality of a number of amino
acid residues in those sites. A good fit of the extended all - trans conformation of
acetylcholine was obtained by manual docking (Sussman et al., 1991). The acyl group
was positioned to make a tetrahedral bond with the Oy of the Ser200 residue of the
catalytic site of the enzyme, while the quaternary group of the choline moiety was placed
within van der Waals distance 3.5 A) of Trp84. The model suggested that the ester
oxygen may interact with the imidazole of His440. Glu199, which was suspected of
serving as an anionic component of the substrate - binding site, appeared to make close
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contacts (~ 3 
Å
) both to one of the quaternary methyl groups and to the a-carbon of the
choline moiety.
It has been proposed that the active site of acetylcholinesterase comprises an
esteratic subsite, containing the catalytic machinery of the enzyme and an 'anionic'
subsite which binds the quaternary group of acetylcholine while the presence of a second,
'peripheral' anionic subsite, distal to the active site was also postulated. The crystal
structures of the complexes of Torpedo Californica acetylcholinesterase with three
reversible inhibitors, EDR [ethyl(3-hydroxyphenyl)dimethylammonium], THA and
decamethonium (DECA) showed the presence of Trp84 and Phe330 in the 'anionic'
subsite and suggested that a distal residue, Trp279, near the top of the gorge is also
involved in ligand binding and may be part of the 'peripheral' anionic site (Harel et al.,
1993 and Silman et al., 1993). In the case of DECA (Figure 15), both quaternary groups
are in van der Waals contact with tryptophan indole rings. One is apposed to that of
Trp84 at the base of the gorge and the distal quaternary group is similarly apposed to the
indole ring of Trp279, 12  distant, at the top of the gorge. In edrophonium (EDR)
(Figure 15), the quaternary group nestles adjacent to the indole of Trp84, a position
virtually equivalent to that of the proximal quaternary group of DECA. The m-hydroxyl
group is positioned between NE2 of His440 and 07 of Ser200, making hydrogen bonds of
3.0 and 3.5  respectively, to two of the three members of the catalytic triad. There is also
a 3.5  hydrogen bond to N of Gly119 which is part of the oxyanion hole of
acetylcholinesterase. THA (Figure 15) was found to be stacked against Trp84, its ring
nitrogen hydrogen-bonding to the main - chain carbonyl oxygen of His440. Its amino
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nitrogen forms a hydrogen bond to a water molecule. In all three complexes, the only
residue undergoing a conspicuous conformational change is Phe330. THA is
'sandwiched' between the rings of Phe330 and Trp84.
Pang et al. performed automated docking studies to predict the binding sites of
Huperzine A (Figure 15), one of the most potent and selective reversible inhibitors of
acetylcholinesterase (Pang et al., 1994a). Their docking strategy, accomplished through
their in-house developed code SYSDOC, allowed for flexibility of both the ligand and
the receptor to permit conformational changes upon binding and accounted for steric,
electrostatic, hydrogen bonding and cation - π  interactions, which are very important in
the binding of acetylcholinesterase. Molecular flexibility was accomplished by generating
complexes with different conformers of the guest and the host. A systematic search
procedure was used to obtain the different guest conformers while for the host, a series of
molecular dynamics calculations was performed, in the presence of water molecules in
the binding cavity to prevent shrinkage or collapse of the binding site during the
dynamics simulations. In each of the derived complexes, the guest was systematically
translated and rotated in the putative binding pocket of the host, within a box
encompassing the space confined by the 14 aromatic amino acid residues on the surface
of the gorge of acetylcholinesterase, to evaluate energetically favorable binding sites for
each available conformation of the host - guest pair. The affinity of binding in the
docking study is estimated from the potential energy of the complex relative to the
potential energies of the guest and host in their free state, assuming that the differences in
entropy and solvation energies between two binding sites can be neglected. The effect of
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the solvent was not included in the calculations. A single low-potential-energy conformer
of Huperzine A (HA) was generated with systematic search and 69 different conformers
of Torpedo Californica AChE with the molecular dynamics simulations. SYSDOC
revealed that HA binds to the bottom of the gorge in of Torpedo Californica AChE above
Trp84 (catalytic domain) and to the opening of the gorge near Trp279 (peripheral
domain). Three partially overlapping subsites were identified in the catalytic domain,
differing in the hydrogen bonding motif (i.e., the lactam hydrogen atom of HA forms a
hydrogen bond with the hydroxyl oxygen atoms of Tyrl121  in subsite 1, Tyrl 30 in subsite
2 and Ser122 in subsite 3; the pyridone oxygen atom of HA forms a hydrogen bond with
the peptide hydrogen atoms of Gly119 in subsite 1, Ser124 in subsite 2 and Asp72 in
subsite 3). These subsites share the cation - π interactions of the ammonium group of HA
with the aromatic groups of Trp84 and Phe330 and the ionic interactions of the
ammonium group with the carboxyl groups of Asp72 and Glu199. In the peripheral
domain there is one site where the ammonium group of HA partially interacts with the
indole ring of Trp279 and is exposed to the solvent, possibly forming hydrogen bonds
with solvent molecules. At this site, the amide hydrogen atom of HA forms a hydrogen
bond with the carbonyl oxygen atom of Arg289 and the pyridone oxygen atom of HA
forms a hydrogen bond with the hydroxyl hydrogen atom of Ser286.
A novel new class of acetylcholinesterase inhibitors are the indanone - piperidine
derivatives of which E-2020 (Figure 15) shows potent inhibitory action in both in vitro
and ex vivo studies. The IC 50 of E-2020 in vitro is 5.3 nM as compared to THA (52 nM)
and physostigmine (0.43 nM). E-2020 inhibits acetylcholinesterase 570 - fold more
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selectively than butyrylcholinesterase. A number of quantitative structure - activity
relationship studies have been published before the availability of the crystal structure of
acetylcholinesterase, focusing on the substituted indanone and benzylpiperidine rings of
indanone-benzylpiperidine reversible inhibitors of acetylcholinesterase (Cardozo et al.,
1992a and Cardozo et al., 1992b). Pang et al. employed their SYSDOC strategy to
perform a docking analysis of E-2020 (Pang et al., 1994b). In terms of size and
flexibility, E-2020 resembles DECA which bonds into the acetylcholinesterase cavity
spanning the whole gorge with its two ammonium groups interacting with Trp84 at the
bottom and Trp279 at the opening of the gorge. E-2020 possesses one ammonium group
though which may interact with either Trp84 or Trp279. It also contains two aromatic
functional groups and exhibits no stereoselectivity (both the R- and S-isomers are equally
active). In their docking simulations, Pang et al. utilized a pre-E-2020 lacking the two
methoxy groups to overcome the computational burden of the large number of torsional
angles present. Their systematic search produced 120 different conformers of (R)-pre-E-
2020 and 104 different conformers of (S)-pre-E-2020 which were docked into the 69
different conformers of Torpedo Californica AChE obtained with the molecular
dynamics simulations. The pre-E-2020 docking revealed that 36 different conformers of
the (R)-isomer and 24 different conformers of the (S) - isomer possess suitable backbone
conformation to fit into the gorge of AChE. Then the docking of E-2020 was performed
by adding the two missing methoxy groups. The docking studies revealed that (R)-E-
2020 possesses three overlapping binding sites and that at each site it spans the whole
gorge. Sites I and II are more favorable than site III based on the calculated binding
energies. At site I, the ammonium group interacts with the aromatic groups of Trp84,
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Phe330 and Tyr334 as well as the carboxy119 group of Asp72; the phenyl group interacts
with the aromatic groups of Trp84 and Phe330; the indanone moiety interacts with the
aromatic groups of Tyr70, Tyr121, Trp279 and Phe290; the carbonyl oxygen atom forms
a hydrogen bond with the amide hydrogen atom of Phe288; and the proton at the
piperidine nitrogen forms a hydrogen bond with the hydroxyl oxygen atom of Tyr121. At
site II, the ammonium group interacts with the aromatic groups of Trp84, Phe330 and
Tyr334 as well as the carboxyl group of Asp72; the phenyl group interacts with the
aromatic groups of Trp84 and His440; the indanone moiety interacts with the aromatic
groups of Tyr70, Tyr334 and Trp279; the carbonyl oxygen atom forms a hydrogen bond
with the hydroxyl hydrogen atom of Tyr121 21; and the proton at the piperidine nitrogen
forms a hydrogen bond with the hydroxyl oxygen atom of Tyr121. At site HI, the
ammonium group interacts with the aromatic groups of Tyr70, Tyr121 21 and Trp279; the
phenyl group interacts with the aromatic group of Trp279; the indanone moiety interacts
with the aromatic groups Trp84, Phe330 and Tyr334; the methoxyl oxygen atom at the 6-
position of the indanone forms a hydrogen bond with the hydroxyl hydrogen atom of
Tyr121 and the proton at the piperidine nitrogen forms a hydrogen bond with the
hydroxyl oxygen atom of Tyr70. Site I is different from site II only in that the hydrogen
bond donor for the carbonyl oxygen atom of E-2020 is the amide hydrogen atom of
Phe288 at site I and the hydroxyl hydrogen atom of Tyr121 at siteII. The two methoxy
groups of (R)-E-2020 are exposed to the solvent at sites I and II.
Similar to the (R)-E-2020, (S)-E-2020 possesses three overlapping binding sites,
two of which (I and II) are more favorable than site III and at each site it spans the whole
gorge. At site I, the ammonium group interacts with the aromatic groups of Trp84 and
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Phe330 as well as the carboxyl group of Asp72; the phenyl group interacts with the
aromatic groups of Trp84, Phe330 and His440; the indanone moiety interacts with the
aromatic groups of Tyr70, Tyr121, Tyr334 and Trp279; the carbonyl oxygen atom forms
a hydrogen bond with the amide hydrogen atom of Phe288; and the proton at the
piperidine nitrogen forms a hydrogen bond with the hydroxyl oxygen atom of Tyr121. At
site II, the ammonium group interacts with the aromatic groups of Trp84, Phe330 and
Tyr334 as well as the carboxyl group of Asp72; the phenyl group interacts with the
aromatic groups of Trp84, Phe330, Tyr334 and His440; the indanone moiety interacts
with the aromatic groups of Tyr70, Tyr334 and Trp279; the carbonyl oxygen atom forms
a hydrogen bond with the hydroxyl hydrogen atom of Tyr121; and the proton at the
piperidine nitrogen forms a hydrogen bond with the hydroxyl oxygen atom of Tyr121. At
site III, the ammonium group interacts with the aromatic groups of Tyr70 and Trp279; the
phenyl group interacts with the aromatic groups of Tyr70 and Trp279; the indanone
moiety interacts with the aromatic groups of Trp84, Phe330, Tyr334 and His440; the
methoxyl oxygen atom at the 6-position of the indanone forms a hydrogen bond with the
amide hydrogen atom of Gly119; and the proton at the piperidine nitrogen forms a
hydrogen bond with the hydroxyl oxygen atom of Tyr70. Similar to (R)-E-2020, site 1 is
different from site II only in that the hydrogen bond donor for the carbonyl oxygen atom
of E-2020 is the amide hydrogen atom of Phe288 at site I and the hydroxyl hydrogen
atom of Tyr121 at site II. The two methoxyl groups of the (S)-isomer are also exposed to
the solvent at sites I and II. The authors concluded that sites 1 and II are the binding sites
for both isomers of E-2020 with site III considered as an 'unlikely' one. They could not
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though specify which site, I or II, is preferred for E-2020. Available structure - activity
data support the availability of both sites I and II to E-2020.
The results of the docking analysis of Pang et al. (Pang et al., 1994b) are
supported by the findings of the study of Villalobos et al. (Villalobos et al., 1994).
Villalobos et al. report on the synthesis, structure-activity relationships and possible mode
of binding of a series of N-benzylpiperidine benzisoxazoles and related derivatives,
compounds that incorporate bioisosteric replacements for the benzoyl moiety and are
devoid of chiral centers that could undergo facile racemization. Their modeling strategy
consisted of an initial manual docking of a benzisoxazole inhibitor within the gorge by
locating possible salt bridge and hydrogen -bonding sites on the protein that could
complement those found on the inhibitor. Asp72 was the only accessible negatively
charged amino acid and the inhibitor was placed in the gorge with the piperidine N-H
oriented in a roughly perpendicular fashion to the plane defined by the carbox.ylate group
of Asp72 and was consistent with the results of the study of Pang et al. (Pang et al.,
1994b) for E-2020. Then, extended molecular dynamics calculations were performed on
this system with explicit solvent. Their results indicate the presence of hydrogen bond
between the positively charged piperidine and the carboxylate side chain of Asp72, 90%
of the time, between the benzisoxazole oxygen and the backbone of Phe288, 93% of
the time. The N-benzyl substituent forms an off-center π - stacking interaction with the
indole side chain of Trp84 with a distance near the minimum reported for a planar π-
stacked interaction between two benzene rings in the gas phase. The phenyl ring of
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Phe330 interacts with the phenyl ring of the benzisoxazole inhibitor and the indole chain
of Trp279 forms an edge - to - face contact pair with the benzisoxazole.
Two putative binding sites for THA and other reversible acetylcholinesterase
inhibitors in the three dimensional structure of Torpedo Californica AChE, one being the
catalytic site and the other near the residues Trp279, Tyr70 and Phe290 were previously
identified. The latter constitutes the so called pheripheral site, located at the opening of
the enzymatic binding pocket, far from the catalytic site at the bottom of the gorge. The
catalytic site has been shown by x-ray crystallography to bind THA but no TI-IA was
found in the pheripheral site. The peripheral site is absent from mammalian
butyrylcholinesterase. Based on the presence of these two binding sites, a series of
alkylene linked bis-THA and alkylene linked benzyl-THA analogs were developed (Pang
et al., 1996). The alkylene linked bis-THA analogs were up to 10000-fold more selective
and 1000-fold more potent than THA in inhibiting rat AChE and yet they required one
simple reaction to synthesize. The best chain length for the bis-THA analogs was
determined experimentally to be 7 methylene groups between the two THA's. A spacing
of 7 methylene units was found to be optimal in the case of the alkylene linked benzyl-
THA analogs which were though less potent than the bis-THA analogs. The results of
that study demonstrate the powerful capabilities provided by the combination of docking
analysis with structure - activity data in the rational drug design process.
Yamamoto et al. performed a docking analysis of a series of benzylamino
acetylcholinesterase inhibitors with a phthalimide, benzoyl or indanone moiety
(Yamamoto et al., 1994). Since there is no available three dimensional structure for the
human AChE, based on its high amino acid sequence homology with the Torpedo
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Californica AChE which was recently crystallized, and due to the fact that the residues
constituting the surface of the ligand - binding, pocket are identical in the two
acetylcholinesterases except for Phe330 which is replaced with Tyr in the Human
enzyme, they replaced Phe330 by Tyr with the identical conformation in the Torpedo
AChE and used that as a model for the Human AChE in their docking studies. The
program DOCK developed by one of the authors was employed in the their docking
analysis. DOCK represents the negative image of the binding site as a cluster of spheres
and docks the ligand molecule by a distance - matching algorithm. A modified version of
DOCK, directed - DOCK combined with a systematic conformational search for docking
flexible ligands was also used. Their results, concerning the behavior of more than 50
compounds, are consistent with the structure - activity data available for the compounds
considered and seem to implicate the same amino acid residues recorded in the docking
studies discussed above, in similar modes of interactions with the ligands. Specifically,
Trp84 and Trp279, located at the bottom of the binding cavity and at the peripheral
hydrophobic site, respectively, are observed to interact with the aromatic groups of the
reversible inhibitors while the hydrogen bonding interactions of the hydroxyl group of the
side chain of Tyr121 with the C = O group(s) of the ligand are proven to be significant for
tight binding.
Recently, Inoue et al., performed a docking study of E-2020 and two of its
analogs that differ in the length of the alkylene chain linking the indanone and the
piperidine moieties (Inoue et al., 1996). The interactions of these compounds with both
the free and the acylated Torpedo Californica AChE enzyme were studied using the
available three-dimensional structure for Torpedo AChE and a Monte Carlo - based
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stochastic docking algorithm developed in-house. Their docking strategy involved a
series of operations consisted of mapping the receptor in a grid - point fashion according
to van der Waals, electrostatic and hydrogen bonding potential characteristics of the
atoms of the active site gorge, generating plausible initial binding-site coordinate sets on
the basis of hydrogen bonding between donor - acceptor heteroatom. pairs of the inhibitor
and the active site gorge of the receptor, initial docking alignments based on steric and
charge complementarity and Monte Carlo sampling to establish intermolecular low-
energy alignments. Five types of key binding interactions were identified namely the
interaction between the indanone ring and the indole chain of Trp279, the interaction
between the methoxy group of the indanone ring and the main chain carbonyl of Arg289,
the interaction between the carbonyl group in the indanone ring and the hydroxy group of
Tyr121 or Tyr70, the interaction between the NH group in the protonated piperidine and
the carboxyl group of Asp72, the phenyl ring of Phe330 or the hydroxy group of Tyr121
and the interaction between the phenyl ring of the benzyl  piperidine and the indole ring of
Trp84. The presence of these binding interactions was evaluated in all the models
obtained through the docking strategy described. In general, all of the docking models
have the benzyl group at the bottom of the active-site cavity and the indanone ring
located at the entrance to the cavity, as realized in previously conducted docking studies.
Since the crystal structure for Torpedo Californica ACNE became available
recently, the number of docking studies concerning reversible acetylcholinesterase
inhibition is limited, yet characterized by a wealth of information which along with
structure - activity data has already led to the design of new more effective and selective
potential treatments of Alzheimer's type senile dementia.
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However, none of the currently existing studies in the literature considers an
integrated picture of the human receptor in the form of some molecular - modeling
methodology derived three-dimensional model in the absence of the more realistic image
provided by crystallography.
The present study consists of an extensive series of docking simulations combined
with structural analysis performed in an attempt to identify the modes of interactions of
three potent reversible acetylcholinesterase inhibitors, for which biological activity data
are available in the literature, with the amino acid residues located in the binding cavity
confined by the active site gorge of the Human acetylcholinesterase considering for the
first time a full three dimensional homology-based model for the human enzyme.
4.2 Methodology
Three analogs of the indanone-benzylpiperidine reversible acetylcholinesterase inhibitors
were considered in the present study (Figure 15). These are compounds 2, 11 and 12 from
the conformational analysis and molecular-shape comparison work of Cardozo et al.
(Cardozo et al., 1992b).
The initial conformations for the three inhibitors were constructed using the
available chemical fragments in SYBYL 6.2. The structures thus obtained were energy
minimized with MAXIMIN2 in SYBYL 6.2 using the TRIPOS force field and their
geometries were subsequently subjected to full optimization using MOPAC 6.0. The
MNDO partial charges of the atoms of the optimized geometries were also calculated
with MOPAC 6.0 within SYBYL 6.2.
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Only the amino acid residues constituting the active site gorge of the human
acetylcholinesterase with the added polar hydrogens were used as the receptor in this
docking study. The corresponding residues were extracted from the three dimensional
homology-based model of the human acetylcholinesterase derived as described in 2.3 and
Kollman charges were assigned to the atoms of the receptor.
The docking searches were performed using AutoDock 2.4 (Morris et al., 1996).
AutoDock uses a Monte Carlo simulated annealing technique for configurational
exploration with a rapid energy evaluation using grid based molecular affinity potential
combining the advantages of a large search space and a robust energy evaluation. The
energy calculations allow the inclusion of van der Waals, electrostatics and hydrogen
bonding interactions. The potential parameters provided with the program were used in
this study with a sigmoidal distance-dependent dielectric function to model solvent
screening. The grids of affinity potentials were calculated on a volume of 20x20x20
Å
and centered on the center of the receptor; the spacing between the grid points was 0.4 .
The extensive docking searches performed in this study involved 100 "jobs" for
each one of the three considered reversible inhibitors. Each "job" consisted of 10
independent runs, each of which begins with the same initial conditions. A run was a
sequence of 50 constant temperature annealing cycles each with a maximum of 30,000
steps rejected or 30,000 steps accepted. Each "job" was seeded with a time-dependent
random number generator seed.
During each constant temperature cycle, random changes are made to the ligand's
current position, orientation and conformation. The resulting new state is then compared
to its predecessor; if the new energy is lower than the last, this new state is accepted. I f
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the new state's energy is higher than the last, this state is accepted probabilistically. The
probability depends on the energy and cycle temperature.
An initial annealing temperature of 400 kcal/mol (RT in the Boltzmann factor)
with a temperature reduction factor of 0.9 to avoid trapping the system in local energy
minima.
Full flexibility of the ligands was allowed with a dihedral step of 1 °  while the
maximum step sizes used for the ligands were 0.1 
Å
 for translation and 1 °  for rotation.
AutoDock 2.4 consists of mainly three modules that accomplish the tasks of the
preparation of the receptor in PDB-like file format, the preparation of the ligand
identifying its rotatable bonds, the construction of the grids of the molecular affinity
potentials and the actual docking searches.
During the course of this study, we developed an environment for the systematic
performance and rapid and efficient evaluation, analysis and visualization of the docking
calculations from AutoDock 2.4. This 'Automated Docking Environment' (ADE) was
developed to minimize user interaction and consists of a series of FORTRAN and Sybyl
Programming Language (SPL) codes and UNIX scripts assisting many of the tasks
involved in initializing and analyzing automated docking calculations. ADE could
therefore be easily applied in database screening for identifying potential leads.
Our docking approach consisted of selecting the lowest energy conformation from
each one of the 100 docking 'jobs' for each of the inhibitors studied. The resulting 100
conformations for each ligand were subsequently visualized in SYBYL 6.2 as part of the
ADE application. The selected 100 conformations of each inhibitor were categorized
according to their geometric (torsional angles) and topologic (docking location within the
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receptor) characteristics into 'patterns'. The lowest energy representative of each 'pattern'
was then used and the geometry of its complex with the full three dimensional model of
the Human AChE was optimized with MAXIMIN2 using the Tripos force field to a
gradient of 0.5 kcal mol d A . The energies of the resulting complexes were recorded and
their structural features analyzed according to five key interactions of the ligand with the
surrounding amino acid residues of the receptor.
4.3 Results
The five key interactions of the ligands with the amino acid residues of the active site
gorge of Human AChE considered were: (K11) the interactions of the carbonyl oxygen of
the indanone ring, (K2) the interactions of the piperidine nitrogen, (K13) the interactions
of the indanone ring with the aromatic groups of the surrounding amino acid residues,
(K14) the interaction of the piperidine ring with the surrounding aromatic groups and
(Kb) the interactions of the methyl substituent of the piperidine nitrogen with the
surrounding aromatic groups.
For Analog 1, twelve different patterns were initially identified. One of the
identified patterns was though engaged in serious steric overlaps with the surrounding
amino acid residues of the active site of Human AChE which were unable to be overcome
and was therefore disregarded. The remaining patterns, indicated as Pattern A to Pattern
K, the percentage of the conformations belonging to each pattern with the energy of the
pattern's lowest energy representative and the energy of its minimized complex with the
human enzyme are given in Table 12. The optimized geometries of the complexes of the
identified patterns with Human AChE are displayed in Figure 28.
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For Analog 2, thirteen patterns were identified indicated as Pattern A to Pattern
M, shown in Figure 29, and for Analog 3, twelve patterns were identified indicated as
Pattern A to Pattern K, which are given in Figure 30. Tables 13 and 14 contain the
percentage of conformations in each pattern, the lowest energy in each pattern and the
energy of the minimized complexes for Analog 2 and Analog 3 respectively.
The analysis of the optimized geometries of the complexes of Human AChE with
the large number of identified patterns for the three ligands studied, resulted in a wealth
of structural information regarding the five key interactions of the three reversible
inhibitors described above with the surrounding amino acid residues of Human AChE.
This information has been summarized in Tables 15-19.
The first and most gratifying observation is the excellent prediction of the
potencies of the three analogs considered by the automated docking calculations. Indeed,
as can be seen in Tables 12 -14, the total binding energies calculated with AutoDock 2.4
for all the identified patterns of Analog 1, the least potent analog, are the highest of all the
three analogs. The corresponding total binding energies for all the patterns of Analog 2
are the lowest, in agreement with the analog's highest inhibitory activity.
The most stable pattern for Analog I, as predicted by AutoDock 2.4, is Pattern F,
with -37.61 kcal/mol, for Analog 2, Pattern D was the most stable with a total binding
energy of -48.72 kcal/mol and for Analog 3, Pattern E, the lowest energy one, has a total
binding energy of -44.08 kcal/mol. Therefore, the rank in energy, El >E3>E2 matches the
rank in potency, Analog I < Analog 3 < Analog 2.
Automated docking calculations can therefore, in spite of their inherent simplicity
in the consideration of the ligand-receptor interactions, successfully predict the binding
6 1
affinity of a series of ligands for a particular enzyme. This is particularly important when
combined with the ease the developed Automated Docking Environment offers to
perform database screening for potential new leads.
The calculated binding energies of the optimized geometries of the patterns of all
the ligands with the human enzyme though, were not as exciting. In this case, Pattern H is
the most stable one for Analog 1 with a total binding energy of - 5,718.623 kcal/mol,
Pattern K had the lowest energy among the patterns of Analog 2 with a total binding
energy of -5,729.222 kcal/mol and for Analog 3, Pattern D was the most stable with a
binding energy of -5,737.691 kcal/mol.
Therefore, in the case of the binding energies of the optimized structures of the
complexes, the order is E3<E2<E1 instead of the expected E2<E3<E1.
For Analog 1, Patterns F and H, the former being the most stable according to
AutoDock binding energy calculations and the latter according to the energy of the
optimized complex geometry, appear to be located in a completely opposite way in the
active site of Human AChE (Figure 31). In Pattern H, the indanone and piperidine rings
are perpendicular to each other as has been confirmed and observed before (Cardozo et
al., 1992b, Inoue et al., 1996). This is not the case for Pattern F. In Pattern H, the
indanone ring is parallel to the indole side chain of Trp117 (Trp 84 in Torpedo AChE).
This mode of interaction has been observed before as constituting a high energy
conformer for E-2020 (Inoue et al., 1996). Pattern F, has the piperidine ring located in the
bottom of the active site gorge of Human AChE. This mode of interaction has been
identified previously (see for example Inoue et al., 1996) as being the most prevalent.
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For Analog 2, Patterns D and K, the former the AutoDock minimum energy and
the latter the minimum energy optimized complex, exhibit the same basic characteristics,
both having the indanone ring and the piperidine ring perpendicular to each other (Figure
32). They also resemble Pattern H of Analog 1. In both patterns, the indanone ring points
towards the bottom of the active site gorge. This has been identified as a high energy
interaction for indanone-piperidine analogs (Inoue et al., 1996). In Pattern D, the
indanone ring is found perpendicularly located with respect to Trp 117, similarly to
Pattern H of Analog I.
Finally, in Analog 3, Pattern D was the minimum energy one for the optimized
complex and Pattern F the most stable as predicted by AutoDock 2.4. Both patterns have
their indanone rings perpendicular to their indanone rings (Figure 33). Their piperidine
rings are also located in the bottom of the active site gorge of the enzyme. This, as
mentioned above, has been recognized as the most common and most likely binding
mode for indanone-piperidine compounds (Inoue et al., 1996, among others). In both
patterns, the indanone ring is also perpendicular to the indole side chain of Trpl 17, as
was previously observed for similar compounds (Inoue et al., 1996).
A further thermodynamic analysis is necessary to be used along with the results of
this study. These kind of calculations are very computationally intensive since they
involve extensive molecular dynamics simulations for configurational sampling and
estimation of free Gibbs energy values. Solvation energy calculations and in particular
calculations of the electrostatic contribution in the binding energies are currently under
way. These calculations generally require fewer computer resources and have been
successfully employed in the prediction of the binding affinities of various ligands to
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their receptors leading to very good agreement with experimental data (for Torpedo
Californica AChE, see Wiodek et al., 1996).
CHAPTER 5
CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE WORK
The controversial role of the electrostatic interactions in the process of steering of
acetylcholine into the active site of acetylcholinesterases was investigated in the present
study.
For the purpose of the simulation of the process of recognition of acetylcholine by
wild type and charge neutralized mutated Human acetylcholinesterases, the three
dimensional, homology-based models of the two enzymes were developed using the
existing crystal structure of Torpedo Californica acetylcholinesterase as a template.
A novel methodology was designed and implemented to simulate the process of
steering of the ligand into the active site of the studied enzymes. The obtained results
suggest that the electrostatic field affects the steering of the ligand only when it is in close
proximity to the entrance of the active site gorge of the enzymes. The steering process
maybe diffusion-controlled when the ligand is further away from the surface of the
enzymes. The electrostatic energy was the predominant form of energy of the complexes
of acetylcholine with the studied acetylcholinesterases. The charge neutralized mutated
Human acetylcholinesterase appeared to retain 35% of the electrostatic field of the
negatively charged wild type Human acetylcholinesterase.
Three irreversible acetylcholinesterase inhibitors were also subjected to the
methodology employed for the natural substrate acetylcholine. Their behavior in the




The global minimum of the studied complexes was consistently located in wild
type Torpedo Californica and Human acetylcholinesterases. The organophosphate DFP
was the only exception to that observation. A further investigation of this phenomenon
and its link to the potency of inhibition of DFP is necessary. The correlation of the
location of the global energy minimum and the diffusion-electrostatics border with
inhibitory potency should also be further examined.
A number of transition states was also revealed by the simulation of the steering
process. The role of the identified transition states should also be elucidated.
The covalent adducts of Torpedo Californica and Human AChE's with selected
organophosphate inhibitors were modeled and subjected to structural analysis. A novel
methodology was designed and implemented to perform the modeling of the covalent
complexes. This methodology can be applied to other covalent docking problems.
The simulations predict the stereoselectivity of Human AChE but not of Torpedo
AChE towards Sarin PS inhibitor. The aging predictions were though in conflict with
previous observations.
The observed hydrophobic interactions of the organophosphate moieties with the
surrounding aromatic amino acid residues of the active site of the enzymes were in very
good agreement with the ones reported in the literature. A new mode of hydrophobic
interaction of the organophosphate moiety with Trp233 (Trp267 in Human AChE) was
identified in this study. The organophosphate moieties interact with the aromatic side
chain of Trp84 in Torpedo but not with the homologous Trp 1 17 residue of Human ACNE.
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The Oy atom of the active site serine in all the complexes modeled was hydrogen-
bonded to Ala201 (Ala235 in Human) and the phosphonyl oxygen to Gly119 (G1)7153 in
Human). The close contacts of the phosphonyl oxygen with Gly118 (Gly152 in Human)
and. Ala201 (Ala235 in Human) were also successfully reproduced.
The proximity of Glu199 (Glu233 in Human), previously suggested as
contributing to the charge stabilization of the leaving carbocation during the aging
process, to the alkyl groups of the organophosphate moieties was not observed.
The organophosphate structural characteristics identified in the present study can
be used for the design of more potent and selective irreversible acetylcholinesterase
inhibitors.
The last part of this study involved a very extensive docking analysis for the
prediction of the binding sites and bioactive conformations, in. Human AChE, of three
reversible acetylcholinesterase inhibitors, belonging to the family of indanone-piperidine
compounds, clinically investigated for the treatment of Alzheimer's type senile dementia.
An Automated. Docking Environment and Methodology was developed based on
AutoDock 2.4 to perform the docking simulations.
A wealth of structural information for the interactions of key chemical groups on
the studied inhibitor analogs with the amino acid residues within the active site of Human
AChE was obtained from the docking calculations. The simulations successfully
reproduced the inhibitory activity of the studied analogs and the binding modes observed
for structurally similar compounds in Torpedo AChE.
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Molecular dynamics calculations coupled to automated docking and explicit
solvent simulations are necessary to more accurately represent the binding environment
of the studied analogs in Human AChE.
The Automated Environment and Methodology developed during the course of
this study, can be directly applied to fastly screen drug databases for the identification of





Table 1. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Torpedo AChE-ACh complex relative to the global energy
minimum with the distance (in 
Å
) of the center of mass of ACh from the C α  atom of the
Ser200 residue of the active site of Torpedo ACNE.
Distance	 Total Energy	 Electrostatic	 Electrostatic van der Waals
Enemy	 Enemy 1-4	 Energy
	
5	 158.357	 165.551	 -2.456	 12.797
	
6	 155.695	 165.542	 1.514	 12.781
	
7	 153.288	 160.990	 1.501	 14.275
	
8	 147.754	 159.827	 -0.233	 12.153
9	 145.669	 161.135	 -2.586	 10.360
	
10	 140.661	 157.191	 -3.749	 7.475
	
11	 152.341	 170.996	 -3.986	 9.339
	
12	 122.832	 150.221	 -4.744	 -0.565
	
13	 143.788	 145.881	 -4.413	 6.403
	
14	 62.441	 61.872	 -9.096	 0.109
	
15	 94.034	 96.661	 -10.954	 2.270
	
16	 0.000	 0.000	 0.000	 0.000
	
17	 118.473	 112.020	 0.233	 10.989
	
18	 128.155	 122.891	 -1.644	 16.564
	
19	 130.698	 133.947	 -2.533	 16.137
	
20	 147.897	 148.758	 -1.333	 20.997
	
21	 148.514	 148.508	 -1.667	 22.335
	
22	 165.768	 177.839	 -5.723	 20.122
	
23	 179.597	 195.166	 -4.307	 21.217
	
74	 189.717	 202.743	 -2.300	 25.706
	
25	 190.783	 202.233	 -2.266	 27.312
	
26	 192.373	 201.659	 -2.263	 29.482
	
27	 194.489	 204.058	 -2.283	 29.259
	
28	 195.631	 204.367	 -2.283	 30.073
	
29	 196.966	 204.446	 -2.291	 31.336
	
30	 195.517	 202.593	 -2.299	 31.747
	
31	 196.501	 203.601	 -2.294	 31.716
	
32	 198.201	 205.113	 -2.301	 31.900
	  33 	198.433 	 205.324 	 -2.300 	 31.924
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Table 2. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Human AChE-ACh complex relative to the global energy
minimum with the distance (in 
Å
) of the center of mass of ACh from the C α  atom of the
Ser234 residue of the active site of Human AChE.
Distance 	 Total Energy 	 Electrostatic 	 Electrostatic van der Waals
Energy	 Energy 1-4 	 Energy
5	 42.878	 35.457	 8.899	 5.102
6	 38.939	 38.585	 6.317	 0.717
7	 1166.671	 -42.932	 17.237	 422.641
8	 23.586	 12.860	 8.281	 -2.096
9	 1070.608	 45.744	 4.018	 373.961
10	 999.984	 -37.042	 12.620	 370.693
11	 45.823	 34.420	 3.632	 8.355
12	 57.056	 41.024	 6.826	 7.225
13	 46.512	 37.386	 4.832	 10.181
14	 37.400	 30.592	 7.196	 3.243
15	 31.755	 20.658	 8.613	 5.344
16	 61.823	 55.955	 3.675	 7.965
17	 0.000	 0.000	 0.000	 0.000
18	 53.188	 49.781	 2.290	 8.788
19	 49.410	 46.343	 3.916	 10.952
20	 34.734	 35.752	 3.777	 7.858
21	 72.747	 71.179	 2.326	 13.150
22	 74.336	 71.765	 -0.551	 16.432
23	 82.564	 83.077	 -0.690	 15.801
24	 91.683	 95.192	 -2.919	 15.112
25	 92.019	 93.248	 -2.698	 17.171
2 6	 92.218	 93.889	 -2.669	 16.705
27	 94.070	 92.876	 -2.679	 19.608
28	 94.872	 93.246	 -2.673	 20.035
29	 95.746	 93.865	 -2.676	 20.289
30	 96.364	 94.315	 -2.674	 20.452
31	 97.079	 94.930	 -2.678	 20.552
32 	 98.542	 96.293	 -2.678	 20.646
33	 99.234	 97.020	 -2.680	 20.612
34	 99.334	 97.077	 -2.680	 20.654
35	 99.505	 97.223	 -2.681	 20.678
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Table 3. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the mutated Human AChE-ACh complex relative to the global
energy minimum with the distance (in 
Å
) of the center of mass of ACh from the Cα  atom
of the Ser234 residue of the active site of muated Human AChE.
Distance	 Total Energy	 Electrostatic	 Electrostatic van der Waals
Energy	 Energy 1-4	 Energy
	
5	 112.992	 86.195	 -1.921	 11.717
	
6	 57.899	 51.105	 -1.471	 0.147
	
7	 1311.024	 105.187	 -3.864	 425.021
	
8	 81.529	 78.111	 0.819	 3.055
	
9	 1845.454	 85.951	 -2.947	 609.846
	
10	 0.000	 0.000	 0.000	 0.000
	
11	 1167.597	 45.310	 -3.876	 410.875
	
12	 39.579	 46.185	 -4.611	 -1.013
	
13	 114.672	 122.427	 -11.077	 4.223
	
14	 44.987	 58.273	 -5.787	 -2.706
	
15	 42.965	 52.871	 -5.269	 -2.400
	
16	 8.490	 18.212	 -4.466	 -2.585
	
17	 12.977	 20.602	 -2.159	 -4.005
	
18	 111.209	 125.116	 -9.541	 2.875
	
19	 151.426	 162.824	 -14.526	 9.740
	
20	 170.820	 173.604	 -16.209	 19.706
	
21	 165.244	 172.176	 -16.321	 17.210
	
22	 174.604	 183.856	 -16.024	 16.809
	
23	 174.109	 182.833	 -16.015	 17.441
	
24	 174.323	 182.431	 -16.011	 18.072
	
25	 173.988	 181.460	 -16.028	 18.746
	
26	 174.738	 180.549	 -16.037	 20.413
	
27	 176.372	 180.925	 -16.045	 21.671
	
28	 177.166	 181.331	 -16.041	 22.059
	
29	 177.210	 179.654	 -16.056	 23.774
	
30	 176.972	 179.815	 -16.052	 23.368
	
31	 177.664	 179.972	 -16.054	 23.905
	
32	 178.354	 180.326	 -16.057	 24.245
	
33	 178.675	 180.517	 -16.059	 24.373
	
34	 178.787	 180.552	 -16.059	 24.452
	
35	 178.838	 180.582	 -16.059	 24.472
	
36	 178.875	 180.606	 -16.060	 24.485
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Table 4. Observed interactions of various organophosphate inhibitors with neighboring
amino acid residues in the acetylcholinesterase-organophospates adducts studied.




 A201/a b 1.69  G118/a 2.75 	 W84,233
Torpedo-Sarin R	 G119/a b l.58  F288,290,331
A201/a 2.97 
H440/c 2.93  A201/a b 1.70  G118/a 3.52 	 W84,233




	       H440/c 3.01  A201/a b 1.66  G118/a 2.64 	 E199/d 3.53
Torpedo-D FP	 H440/c 3.54  G119/a b 1.60 	 W233,H440
	
A201/a 3.16 	 F288,290,331
H478/c 2.69  A235/a b 1.66     G152/a 3.08 	 W267




H478/c 3.41  A235/a b 1.72  G152/a 3.88 	 W267
Human-Sarin S	 G153/a b l.59 	 H478
	
A235/a 3.13 	 F326,328,369
	
H478/c 2.88  A235/a b 1.70  G152/a 3.02 	 E233/d 3.95 A
I-Iuman-DFP	 H478/c 3.28  G153/a b 1.59 	 W267,H478
	
A235/a 3.07 	 F326,328,369
Notations: a interaction with amide hydrogen, b hydrogen bond interaction, c interaction
with Nε2 of His, d interaction with oxygens of Glu sidechains.
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Table 5. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal /viol) of the Torpedo Californica AChE-Sarin PR complex relative to the
global energy minimum with the distance (in 
Å
) of the center of mass of Sarin PR from
the Cα  atom of the Ser200 residue of the active site of Torpedo ACNE.
Distance 	 Total Energy 	 Electrostatic 	 Electrostatic van der Waais
Energy 	 Energy 1-4 	 Energy 
5 	 31.281 	 32.442	 0.194 	 2.915
6 	 29.373 	 33.004 	 0.800 	 -0.635
7 	 24.257 	 32.531 	 -2.140 	 -1.326
8 	 23.919 	 27.645 	 -3.020 	 2.650
9 	 26.054 	 31.105 	 -2.636 	 1.000
10 	 19.861 	 29.310 	 -2.869 	 0.560
11 	 17.179 	 22.371 	 -7.570 	 0.809
12 	 21.184 	 16.603 	 -7722	 3.948
13 	 35.020 	 28.762	 -2)91 	 4.950
14 	 18.525 	 17.808 	 -1.695 	 1.827
15 	 32.685 	 29.001 	 -0.798 	 3.962
16 	 1406.858 	 8.182 	 -8.937 	 567.667
17 	 10.062 	 -2.093 	 0.501 	 1.791
18 	 0.000 	 0.000 	 0.000 	 0.000
19 	 32.527 	 24.278 	 -l.745 	 5.095
20 	 30.554 	 26.325 	 -2.173 	 5.073
21 	 20.163 	 26.799 	 -1.632 	 1.480
22 	 53.443 	 58.527 	 -2.221 	 7.040
23 	 25.002 	 30.755 	 -2.909 	 6.629
24 	 56.099 	 61.744 	 -2.502	 10.358
25 	 57.520 	 62.281 	 -2.520 	 11.257
26 	 58.815 	 62.412 	 -2.530 	 12.458
27 	 59.201 	 62.010 	 -2.542 	 13.259
28 	 58.653 	 60.983 	 -2.585 	 13.773
29 	 59.272 	 61.193 	 -2.574 	 14.142
30 	 59.006 	 60.921 	 -2.584 	 14.174
31 	 59.232 	 61.098 	 -2.578 	 14.220
32	 59.999 	 61.813 	 -2.579 	 14.265
33 	 60.103 	 61.913 	 -2.575 	 14.268
34 	 60.103 	 61.913 	 -2.575 	 14.268
35 	 60.103 	 61.913 	 -2.575 	 14.268
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Table 6. Variation of the total, electrostatic . , 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Torpedo Californica AChE-Sarin PS complex relative to the
global energy minimum with the distance (in 
Å
) of the center of mass of Sarin PS from
the Cα  atom of the Ser200 residue of the active site of Torpedo AChE.
Distance	 Total Energy	 Electrostatic	 Electrostatic van der Waals
Energy	 Energy 1-4	 Energy 
5	 74.899	 80.532	 l.298	 7.183
6	 83.171	 89.627	 2.770	 7.682
7	 80.210	 88.036	 4.263	 5.826
8	 85.832	 87.812	 2.284	 11.368
9	 85.956	 83.817	 3.286	 12.994
10	 69.456	 81.735	 2.691	 4.824
11	 75.283	 85.006	 2.527	 6.041
12	 71.703	 81.129	 2.657	 5.701
13	 67.361	 68.218	 3.631	 4.685
14	 68.017	 68.569	 3.289	 7.268
15	 75.667	 74.522	 2.332	 9.452
16	 93.752	 78.421	 1.761	 10.334
17	 0.000	 0.000	 0.000	 0.000
18	 86.675	 73.851	 5.266	 15.884
19	 86.821	 83.717	 5.257	 13.050
20	 88.272	 80.773	 2.742	 18.032
21	 88.251	 90.293	 3.427	 12.832
22	 108.917	 118.714	 2.946	 14.013
23	 104.355	 113.527	 2.645	 15.842
24	 106.016	 113.574	 2.539	 17.722
25	 108.081	 114.081	 2.502	 19.363
26	 109.125	 114.285	 2.488	 20.233
27	 118.087	 114.372	 2.455	 21.156
28	 109.852	 113.991	 2.444	 21.339
29	 111.389	 115.172	 2.403	 21.714
30	 110.816	 114.328	 7.385	 21.999
31	 110.815	 114.290	 2.398	 22.031
32	 111.512	 114.935	 7.383	 22.083
33	 111.637	 115.063	 2.388	 22.086
34	 111.637	 115.063	 2.388	 22.086
35	 111.637	 115.063	 2.388	 22.086
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Table 7. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Torpedo Californica AChE-DFP complex relative to the
global energy minimum with the distance (in 
Å
) of the center of mass of DR' from the
Cα  atom of the Ser200 residue of the active site of Torpedo ACNE.
Distance 	 Total Energy 	 Electrostatic 	 Electrostatic van der Waals
Energy 	 Energy 1-4 	 Energy 	
5	 7.150	 -17.999	 6.661	 7.548
6	 26.145	 14.186	 3.432	 7.056
7	 27.859	 16.224	 0.336	 4.846
8	 18.591	 12.087	 -1.237	 7.705
9	 21.760	 11.306	 -2.153	 7.996
10	 24.671	 15.454	 -0.655	 6.824
11	 0.000	 0.000	 0.000	 0.000
12	 8.407	 -1.887	 -1.821	 -0.053
13	 32.523	 -51.584	 5.277	 -6.591
14	 20.631	 5.070	 -2.470	 2.074
15	 1003.948	 -6.855	 2.681	 361.987
16	 28.182	 -0.077	 -4.748	 6.120
17	 12.672	 -8.492	 4.894	 8.759
18	 37.376	 8.255	 2.122	 14.183
19	 17.727	 1.663	 0.377	 9.612
20	 24.854	 11.624	 1.629	 10.277
21	 18.345	 8.228	 0.046	 9.132
22	 17.667	 11.678	 -0.356	 9.793
23	 51.885	 46.354	 -0.517	 17.130
24	 50.018	 44.715	 -1.283	 16.939
25	 54.783	 47.322	 0.722	 20.636
26	 55.530	 46.479	 0.731	 22.227
27	 55.906	 46.316	 0.732	 22.771
28	 55.602	 45.665	 0.732	 73.110
29	 55.559	 45.423	 0.735	 23.306
30	 54.482	 44.291	 0.734	 23.374
31	 56.433	 46.133	 0.733	 23.473
32	 56.455	 46.149	 0.733	 23.479
33	 56.581	 46.266	 0.736	 23.486
34	 56.581	 46.266	 0.736	 23.486
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Table 8. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Human AChE-Sarin PR complex relative to the global energy
minimum with the distance (in 
Å
) of the center of mass of Sarin PR from the C α  atom of
the Ser234 residue of the active site of Human AChE.
Distance	 Total Energy	 Electrostatic	 Electrostatic van der Waals
Energy	 Energy 1-4	 Energy
5	 18.807	 1.796	 8.466	 4.022
	
6	 27.475	 26.219	 4.054	 -2.182
	
7	 25.094	 23.945	 -0.428	 0.690
	
8	 18.340	 6.160	 3.924	 1.638
	
9	 19.549	 14.852	 1.719	 -0.109
	
10	 11.447	 14.715	 -0.794	 -3.695
11	 32.466	 22.252	 2.638	 -0.559
	
12	 6.958	 12.354	 -4.297	 -1.519
	
13	 19.705	 3.877	 -l.087	 5.526
	
14	 1y27	 -1.643	 -1.668	 5.904
	
15	 0.000	 0.000	 0.000	 0.000
	
16	 10.759	 15.854	 2.000	 -0.066
	
17	 37.447	 38.844	 -2.682	 3.764
	
18	 5.563	 10.299	 0.789	 -1.293
	
19	 25.136	 26.795	 -0.228	 2.481
	
20	 36.442	 39.142	 -2.233	 5.344
	
21	 37.609	 41.346	 -2.190	 4.933
	
22	 45.338	 51.084	 -3.349	 6.211
	
23	 45.727	 50.425	 -3.279	 7.178
	
24	 46.189	 50.121	 -3.213	 8.248
	
25	 47.687	 49.785	 -3.281	 10.090
	
26	 47.451	 49.160	 -3.249	 10.473
	
27	 47.912	 49.287	 -3.232	 10.801
	
28	 48.332	 49.476	 -3.736	 11.039
	
29	 48.623	 49.630	 -3.223	 11.173
	
30	 49.383	 50.327	 -3.226	 11.230
	
31	 49.381	 50.321	 -3.224	 11.237
	
32	 50.040	 50.929	 -3.224	 11.285
	
33	 50.040	 50.929	 -3.224	 11.285
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Table 9. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Human AChE-Sarin PS complex relative to the global energy
minimum with the distance (in 
Å
) of the center of mass of Sarin PS from the C α  atom of
the Ser234 residue of the active site of Human ACNE.
Distance 	 Total Energy 	 Electrostatic 	 Electrostatic van der Waals
Energy 	 Energy 1-4 	 Energy 	
5	 36.113	 33.052	 0.593	 3.819
6	 10.019	 6.971	 2.011	 3.216
7	 35.643	 21.934	 1.371	 5.405
8	 4.315	 -1.502	 1.500	 2.177
9	 14.694	 12.805	 -0.032	 3.152
10	 19.870	 22.800	 -1.138	 1.362
11	 0.000	 0.000	 0.000	 0.000
12	 7.496	 4.201	 0.719	 -0.721
13	 23.149	 16.390	 -3.097	 7.698
14	 8.286	 10.857	 -3.375	 2.951
15	 11.921	 15.412	 -3.157	 4.835
16	 16.386	 5.298	 3.501	 9.720
17	 14.244	 10.507	 -0.641	 9.085
18	 33.267	 31.447	 -3.989	 7.372
19	 11.476	 10.656	 0.339	 8.003
20	 13.362	 9.430	 0.063	 11.159
21	 32.926	 28.586	 -1.796	 13.519
22	 44.617	 42.866	 -3.128	 14.002
23	 34.294	 34.844	 -2.074	 12.569
24	 41.666	 41.266	 -2.875	 13.781
25	 43.082	 41.599	 -2.845	 14.896
26	 43.766	 41.552	 -2.844	 15.613
27	 44.477	 41.795	 -2.849	 16.093
28	 43.949	 41.040	 -2.849	 16.323
29	 44.632	 41.697	 -2.831	 16.341
30	 44.843	 41.821	 -2.842	 16.435
31	 44.927	 41.890	 -2.842	 16.449
32	 45.558	 42.461	 -2.843	 16.508
33	 45.558	 42.461	 -2.843	 16.508
7 8
Table 10. Variation of the total, electrostatic, 1-4 electrostatic and van der Waals energy
values (in kcal/mol) of the Human AChE-DFP complex relative to the global energy
minimum with the distance (in
Å
) of the center of mass of DFP from the C α  atom of the
Ser234 residue of the active site of Human AChE.
Distance	 Total Energy	 Electrostatic	 Electrostatic van der Waals
Energy 	 Energy 1-4 	 Energy 
5	 0.000	 0.000	 0.000	 0.000
6	 62.395	 54.845	 -5.713	 8.262
7	 63.938	 56.173	 -7.608	 11.639
8	 15.924	 7.964	 -3.800	 2.107
9	 43.811	 46.199	 -8.233	 1.814
10	 1173.214	 44.855	 -12.885	 442.904
11	 176.092	 58.870	 -7.095	 85.801
12	 52.295	 36.035	 -3.106	 12.318
13	 48.450	 41.308	 -7.117	 4.548
14	 46.886	 53.830	 -11.080	 6.112
15	 64.420	 69.932	 -12.358	 8.763
16	 56.716	 62.205	 -7.948	 8.015
17	 62.827	 58.319	 -8.859	 14.548
18	 50.695	 48.895	 -7.419	 7.957
19	 68.347	 73.091	 -9.134	 9.541
20	 52.727	 60.955	 -8.160	 9.470
21	 91.345	 94.092	 -12.557	 18.446
22	 82.507	 90.900	 -13.167	 16.385
23	 87.640	 97.008	 -13.044	 15.625
24	 91.873	 104.944	 -15.320	 14.009
25	 92.776	 103.820	 -15.313	 16.073
26	 92.992	 102.437	 -15.309	 17.676
27	 92.108	 101.308	 -15.301	 17.928
28	 92.239	 101.227	 -15.299	 18.140
29	 92.697	 101.494	 -15.299	 18.332
30	 92.685	 101.356	 -15.302	 18.457
31	 93.086	 101.696	 -15.302	 18.517
32 	 94.119	 102.700	 -15.299	 18.543
33	 94.119	 102.700	 -15.299	 18.543
2416Torpedo - ACh 5	 11	 13	 15
18 24Torpedo - Sarin PR 5	 9	 13	 16	 19	 22
2217Torpedo - Sarin PS 6	 9	 11	 16
2311Torpedo DFP 7	 10	 13	 15	 18	 20
24171111177077 - ACh 5	 7	 9	 12	 l.6	 18
1910mut I I 71117C111 - ACh 5	 7	 9	 11	 13
15 22 6	 9	 11 	 13	 17Human - Sarin PR
2411 5	 7	 10	 13	 16	 18	 22- Sarin PS
5 21Human - DFP 7	 10	 15	 17	 19
Table 11. Summary of the results of the simulation of the steering process of selected ligands and inhibitors into the active site gorge of











Table 12. The percentage of conformations belonging to each pattern, the energy (in
kcal/mol) of each pattern's lowest energy representative and the energy (in kcal/mol) of
the complex of the lowest energy conformation of each pattern with Human AChE for
Analog 1 (IC50 = 8.4 nM). The lowest energy pattern is highlighted in bold and italic
Pattern 	Percentage	 Lowest Energy	 Energy of Complex
A	 25	 -37.24	 -5,653.521
B 17	 -37.17	 -5,643.561
C	 1	 -33.20	 -5,654.309
D 1	 -36.82	 -5,655.658
E 1	 -33.65	 -5,676.238
F	 29	 -37.61	 -5,665.721
G	 5	 -33.77	 -5,649.411
H 10	 -35.48	 -5,718.623
I	 2	 -37.19	 -5,666.181
J	 2	 -35.57	 -5,648.632
K 1	 -32.95	 -5,661.296
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Table 13. The percentage of conformations belonging to each pattern, the energy (in
kcal/mol) of each pattern's lowest energy representative and the energy (in kcal/mol) of
the complex of the lowest energy conformation of each pattern with Human AChE for
Analog 2 (IC50 = 0.82 nM). The lowest energy pattern is highlighted in bold and italic.
Pattern 	 Percentage	 Lowest Energy	 Energy of Complex
A	 43	 -47.22	 -5,663.377
B 9	 -45.39	 -5,654.094
C	 3	 -44.74	 -5,681.411
D 9	 -48.72	 -5, 654. 852
E 13	 -47.85	 -5,675.134
F	 6	 -46.78	 -5,652.158
G	 3	 -44.87	 -5,698.812
H 7	 -43.54	 -5,658.358
I	 1	 -44.14	 -5,658.850
J	 3	 -45.03	 -5,686.708
K 1	 -45.12 	 -5,729.222
L 1 	 -42.57	 -5,649.637
M	 1	 -43.90	 -5,639.814
8 - 2
Table 14. The percentage of conformations belonging to each pattern, the energy (in
kcal/mol) of each pattern's lowest energy representative and the energy (in kcal/mol) of
the complex of the lowest energy conformation of each pattern with Human AChE  for
Analog 3 (IC50 = 3.0 nM). The lowest energy pattern is highlighted in bold and italic.
Pattern 	 Percentage 	 Lowest Energy 	 Energy. of Complex
A	 14	 -40 71	 -5,676.727
B 18	 -42.74	 -5,671.110
C	 2	 -41.37	 -5,664.049
D 1 	 -40.34 	 -5,737.691
E 	 18 	 -44.08 	 -5,671.496
F	 13	 -42.27	 -5,662.448
G 14	 -41.21	 -5,691.094
H 7	 -41.89	 -5,721.157
I	 11	 -41.05	 -5,679.341
J	 1	 -41.62	 -5,690.431
K 1	 -36.74	 -5,661.910
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Table 15. Observed interactions (distances in 
Å
) of the carbonyl oxygen atom (KU) of
the indanone ring of the three analogs studied with atoms of the surrounding amino acid
residues of Human AChE. The lowest energy pattern of each analog is highlighted.
Pattern	 Analog 1	 Analog 2	 Analog 3
(1050 --- 8.4 nM)	 (1050 0.82 nM)	 (IC50 3.0 nM)
	A	 0152/a 3.50	 D105/a 3.98	 S156/c 3.50
S156/c 2.96
	B	 G152/a 3.95	 Y164/c 3.78	 Y480/c 3.70
	C	 Y368/c 3.95	 G152/a 3.32
S234/c 3.45
	D	 - 	 0152/0 3.68	 G152/a 3.85
Y164/c 3.73
	5156/c 3.92	 S156/b c2.27	 S156/b c 2.56
Y155/c 3.95	 G157/a 4.00
S156/c 3.33
0152/a 3.41	 Y164/c 3.27
S234/c 3.44
	H	 Y368/c 2.50	 S156/b c 2.29	 G152/a 3.30
	Y372/c 3.53	 S234/c 3.21
	
1	 S156/c 3.02	 G151/a3.63
G152/a 2.96
Y164/c 2.81




M N/A                   N118/a 3.74 	 N/A
Notations: a interaction with amide hydrogen, b hydrogen bond interaction, c interaction
with hydroxyl hydrogen.
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Table 16. Observed interactions (distances in 
Å
) of the nitrogen atom (K11) of the
piperidine ring of the three analogs studied with atoms of the surrounding amino acid
residues of  Human AChE. The lowest energy pattern of each analog is highlighted.
Pattern	 Analog 1	 Analog 2	 Analog 3
(/C50 = 8.4 nM)	 (1050 = 0.82 nM)	 (IC50 = 3.0 11M)
A	 A158/a b 1.81	 0153/a 3.44	 -
B A158/a 3.13                   G153/a 3.40	 Al58/a 3.83




	 G153/a 3.40	 G152/a3.71
E 0157/a 3.97
A158/a 3.43
F G157/a 3.75	 0151/a 3.95	 6153/a 3.40
	A 158/a 3.22	 A158/a 3.95
Y164/c 3.36
G	 0152/a 3.37	 0151/a 3.94	 0153/a 3.48
	
G153/a 3.34	 Y164/c 3.35
S234/c 3.64
H G153/a 3.42	 G480/a 3.97                  G157/a 3.61	
I	 -	 G153/a 3.41	 -
J	 A158/a 3.54	 G153/a 3.52	 -
K
2/a 3.81
	 G153/a 3.45	G157/a 3.24
N/A
	 0153/a 3.86                       N/A
M	 	 -	 N/A
Notations: a interaction with amide hydrogen, b hydrogen bond interaction, c interaction
with hydroxyl hydrogen.
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Table 17. Observed interactions (symbols in parentheses, i.e. I perpendicular) of the
indanone ring (K13) of the three analogs studied with aromatic sidechains of the
surrounding amino acid residues of Human AChE. The lowest energy pattern of each
analog is highlighted.
Pattern	 Analog 1	 Analog 2	 Analog 3
(IC50= 8.4 nM) 	 (IC50= 0.82 nM)	 (IC50= 3.0 nM)
A	 'W117, H478 (-I-)	 Y164 (L)
B W117 (II) 	 Y164	 Y155, F369, Y368,
1-1478
C	 H478 (-I-), Y368 (L)	 F369, Yl55, H478	 Y155, F369, Y368,
F369 (L)	 H478
D W117(II) 	 W117 (II), Y164	 Y155(L) F369(L)
H478 (L)
W117 (II), H478 (L) 	H478, Yl55	 Y155 ( 9, F369 ( L)
Y368	 H478 (L)
F	 Y368, H478	 Y155 (L),F328(L)	 Y164 ((I), W117 (Ii)
F369 ( L), 1-1478 ( L)
G Y164 (-1-)	 Y155 (L), F328( 1-)	 P119
F369 ( L), H478 ( L)
H	 W117 (II) 	 Y164 ( 1-)	 Y155 ( L), F328( L)
F369 ( L), 1-1478 ( 1-)
I	 H478 (- 1-), F369 (i)	 Y164	 Y164 (L)
F328 (1), Y155 (-1-)
Y368 ( L)	 Y164( L)	 Yl55 
(L)
, F328(L)
F369 ( L), 1-1478 ( L)
K
,
W117 	Y1 4( )





M	 	 Y164 	 N/A
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Table 18. Observed hydrophobic interactions (symbols in parentheses, i.e.
perpendicular) of the piperidine ring (K14) of the three analogs studied with aromatic
sidechains of the surrounding amino acid residues of Human ACNE. The lowest energy
pattern of each analog is highlighted.
Pattern 	 Analog 1 	 Analog 2 	 Analog 3
(IC50= 8.4 nM)	 (IC50= 0.82 nM)	 (IC50 = 3.0 mil)
A	 Y164 (1)	 Y155 ( F369 ( L),	 Y480, H478
H478 ( L)	 W117
(II)
B Y164 (1), Y150 (1)	 Y155 (L.), F369 (L), W117 (L), Yl64 (11;
14478 ( L)
C 	 Y164 (1)	 Y164II), W117 (1-)	 Yl64
D	
W117 (




Y155(L), F369(L),Y368                                                                              H478(L)
F Y368, H478 Y155( L), F328( L
)     Y164(II), W117(II)
F369(L), H478(L)
G Y164(L)                 Y155( L),  F328( L
) 11155 ( I), F369
( L
	 W117(11) 	 Y164 (1)
H478 
I	 II) 	 Y155, F369,11478	 Y368, F369, l-1478
J 	 Y368(L)	 Y164(L)                       Y155(L),F328(L)
F369(L),H478(L)





M	 N/A	 Y164(1 	 N/A
8 7
Table 19. Observed hydrophobic interactions (symbols in parentheses, i.e. -I-
perpendicular) of the methyl substituent of the piperidine ring (K13) of the three analogs
studied with aromatic sidechains of the surrounding amino acid residues of Human
AChE. The lowest energy pattern of each analog is highlighted.
Pattern 	 Analog 1 	 Analog 2 	 Analog 3
(IC50 = 8.4 nM)	 (1050= 0.82 nM)	 (1050= 3.0 nM)
A- F326 (II), W267(II)	 Y480B
F326 (II),F326	 P119 (II)
C	 P119	 Y150(<)
	W267 
 (II), F326 (
	Y150 (II), Y164
F328
E 	 Y150, Y164	 Y480 (3-)	 Y480 09
Y150	 F326 (ID, W267 (II)
F328
G	 F326, F328	 Y150	 F326 (ID, W267 (II)
F328
H 	 W267 (II), F326 (II) 	 Y480	 Y150 (ID
1	 F326 (II), W267 (II)	 F369 (II)
F328	 Y155,17328




F326, F369, Y155	 F326 (II), W267 ( 	 Y164
P328(II)	 F328
L 	 N/A	 Y155, F369	 N/A
F328 (II)
M 	 N/A	 Y480(II), H478	 N/A
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Table 2Q. List of amino acid residues of the Human AChE involved in interactions with
the identified patterns of the three reversible inhibitors studied and their homologous
residues in Torpedo Californica AChE.



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 16. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate




Figure 17. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate




Figure 18. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate
moiety of Sarin PR with surrounding amino acid residues of Human
A
108
Figure 19. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate
moiety of Sarin PS with surrounding amino acid residues of Human AChE.
109
B
Figure 20. Hydrogen bonding (A) and hydrophoblic interactions (B) of the organophosphate
moiety of DFP with surrounding amino acid  residues of Torpedo Californica AChE.
A
110
Figure 21. Hydrogen bonding (A) and hydrophobic interactions (B) of the organophosphate
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